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ABSTRACT
Background: Despite advancements in surgical techniques through the use of robotic
assisted radical prostatectomy, urinary incontinence remains the most common side effect
following surgery affecting men s quality of life.
Objective: To explore the role of a single pre-operative pelvic floor muscle training
session. To determine if men who receive the training session have a decrease incidence
of incontinence post-op, whether pelvic floor muscle strength pre-operatively is an
independent predictor of urinary incontinence, and the impact of incontinence on quality
of life in men following a robotic-assisted radical prostatectomy in the early stages postoperatively.
Design: A two part study with a retrospective portion and a prospective pilot cohort
study.
Method: Electronic medical record review of 140 men who have undergone robotic
assisted radical prostatectomy was conducted for the retrospective study. For the
prospective study, twenty consecutive patients who underwent robotic assisted radical
prostatectomy were randomized into 2 groups, the intervention group received the pelvic
floor muscle training and the control group did not. Outcome measures included pelvic
floor muscle strength, 24 hour pad test, and quality of life instruments.
Results: Urinary incontinence was significantly less at 6 weeks post-op with one session
of pre-op pelvic floor muscle training. None of the demographics and PF muscle
performance pre-op, with the exception of race, related to incontinence post-op. The
pelvic floor muscle training session alone was related to improved continence post-op.
Pelvic floor muscle strength (p = .038) and endurance (p <.001) improved over time and
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more rapidly in the pelvic floor muscle training group with coinciding diminished
severity of incontinence. Functional impact of incontinence decreases over time in both
groups with a significantly lesser impact in the PFMT group (IIQ-7, p = .008, UCLA, p
<.001). The impact in the PFMT group at 6 weeks was less than at 3 months in the
control group.
Conclusions: The results of this study indicate that a single, pre-operative pelvic floor
muscle training session may improve early continence and quality of life outcomes after
robotic assisted radical prostatectomy. Larger scale studies should be conducted to
corroborate the findings.
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CHAPTER 1: INTRODUCTION
OVERVIEW
Prostate carcinoma (CA) has been the second leading cause of death in men in America
for decades. Since the implementation in 1988 of an annual Prostate-Specific Antigen
(PSA) and Digital Rectal Examination (DRE) screening, more men are being diagnosed
with the condition (up to 15%) and are being diagnosed at an early age (average of 66
years old).1,2 The available treatments for prostate CA, include: watchful waiting,
cryosurgery, radiation, chemotherapy, hormone therapy, vaccine treatment, bone-directed
treatment, and surgery for radical prostatectomy.2 Prostatectomy remains the treatment of
choice and may be performed through a number of approaches: traditional open
approach, retropubic or perineal, laparoscopic, or more recently, through the da Vinci
robotic procedure. The robotic procedure has gained popularity amongst surgeons as the
system provides more maneuverability and more precision when moving the instruments
than the standard laparoscopic approach and decreased blood loss is associated with the
more minimally invasive technique. The extent of the procedures is dictated by the level
of the Gleason score and pathology stage of the CA. The risks in all procedures result
from the degree of the damage rendered to the surrounding peritoneal fascia, bladder
neck, and neurovascular bundle (NVB). The techniques gear to preserve or reconstruct
those structures peri-operatively, therefore lower the chances of side effects.3-10 The most
common side effects of all procedures are impotence (e.g, erectile dysfunction, changes
in orgasm, penis length, loss of fertility) and urinary incontinence (e.g, stress, urge,
overflow or continuous). Even with the precision of the robotic assisted prostatectomy,
none of the approaches differ in terms of side effects.2,11-17 As many as 87% of men may
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experience incontinence immediately following prostatectomy1,2,18 and the likelihood of
its occurrence increases with age,19-23 thus impacting one s quality of life.
This research explored the role of a pre-operative pelvic floor muscle training (PFMT)
session, and whether pelvic floor (PF) muscle strength pre-operatively is a predictor of
urinary incontinence and the impact of incontinence on quality of life in men following a
robotic-assisted radical prostatectomy in the early stages post-operatively.
PROBLEM STATEMENT AND GOAL
Multiple systematic reviews have concluded to the benefits of PFMT in reducing the
incidence of incontinence in females after giving birth and/or following urogynecological interventions.24-27 Recently, studies have also shown the same benefits in
addressing post-prostatectomy incontinence in men in the short-term28-47 but the longterm benefits have been inconclusive from the results of a number of systematic
reviews.48,49 Two studies have correlated PF muscle weakness to the incidence of
incontinence following a radical prostatectomy.50,51 The study by Ocampo-Trujillo et al52
shows histologic PF muscle changes with a pre-operative PFMT program. The rationale
of PFMT, which focuses on building strength, endurance, speed and coordination of the
PF muscles in various situations, is that it improves PF tone and organ support, thereby
reducing the symptoms of incontinence.50 However, only a few studies discuss the
benefits of a pre-operative PFMT session in reducing the severity and period of
incontinence post-operative53-56while others show no benefit.57,58
Physical therapists who specialize in the treatment of PF muscle dysfunction are
positioned in a role of expert clinicians in the assessment of PF strength and the
management of urinary incontinence. There are a variety of ways to assess PF strength.
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The most commonly used tools or techniques used by physical therapists are digital
palpation, perineometer, sEMG, the Laycock modified Oxford grading system (0-5 point
scale) and the PERFECT scheme.59,60,61
This study explored the effect of receiving a one-time pre-operative PFMT on the
occurrence of post-operative urinary incontinence and the impact on quality of life in
men following a da Vinci robotic-assisted radical prostatectomy. It was hypothesized
that with improved PF awareness and strength, patients who received the PFMT session
pre-operatively would not suffer from incontinence to the degree and length of time postoperatively as those patients who did not receive the pre-operative training. The benefits
would occur regardless of the pre-operative PF muscle strength, patient s age, Gleason
score, T-stage, or NVB preservation
RELEVANCE AND SIGNIFICANCE
There are some conflicting thoughts on the long term benefits of PFMT in the treatment
of incontinence for men following a robotic-assisted prostatectomy, as well as in the
benefits of pre-operative PFMT in the prevention of post-operative urinary incontinence.
However, there is value if PFMT could aid those patients to improve their quality of life
through decreased severity and period of post-operative urinary incontinence
immediately following surgery. Improving one s awareness of PF muscles and
improving the PF strength prior to prostatectomy could potentially improve organ support
and improve the ability to constrict the urinary flow in the urethra during functional
activities, thus decreasing the chance of incidence of urinary incontinence.41-44 The
improved continence would save on the cost that could result from dealing with
incontinence post-operatively, such as having to use pads, prolonged use of physical
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therapy services post-operatively when the PF muscles have been damaged, and possible
need for further more invasive interventions (such as injection of urethral bulking agents,
use of clamps, sub-urethral slings, or artificial urinary sphincter implantation).30,62,63
RESEARCH QUESTIONS
Therefore, this research proposed two phases to answer the following questions:
Phase one was a retrospective study:
1. Do men who receive a one-time pre-op PFMT have less incontinence
following the robotic assisted daVinci prostatectomy than men who do not?
2. What are the differences in PF muscle strength and demographic variables
between patients with more vs. fewer incidence of urinary incontinence?
Phase two was a prospective randomized pilot study:
3. Do men who present with the associating factors identified in the retrospective
study have less symptoms of incontinence following the robotic assisted
daVinci prostatectomy vs. those who do not?
4. Do men who have received the one-time pre-op PFMT session present with
improved PF strength, less incontinence, and better quality of life scores in the
early stages following the robotic assisted daVinci prostatectomy compared to
those who did not?
APPROACH
This research consisted of two parts. The first part was a retrospective study. After
appropriate Nova Southeastern University IRB approval was received; data was collected
from electronic chart reviews of patients who have undergone a da Vinci robotic
prostatectomy, with and without completion of a one-time pre-operative PFMT session.
4

Data was retrieved from both the physicians and the physical therapists records taken
from their medical history and their respective physical examinations. The pre-operative
demographic information was recorded, including: age, ethnicity, level of education,
symptoms if any, and stage of prostate CA (Gleason score and clinical T-stage). Intraoperative factors, such as bladder neck and neurovascular bundle preservation were also
noted, as well as PF strength and endurance from those patients who have received the
one-time pre-operative PFMT by the physical therapist. Post-operative information was
collected at 3 points in time: at the post-op follow-up appointments with the surgeon at 6
weeks, 3 months, and one year following the prostatectomy. Post-operative information
included incidence and level of urinary incontinence through use and changes of
pads/day. Additional information was also gathered, such as other post-operative
complications, need of post-operative physical therapy, or whether further intervention
was recommended or performed.
The second portion was a small cohort prospective study. Data was collected preoperatively and post-operatively at 6 weeks and 3 months from a small sample of
convenience of 20 patients who had undergone the da Vinci prostatectomy. The subjects
were randomly assigned into 2 groups, one received the one-time pre-operative PFMT
session and the other did not. Outcome measures included degree of incontinence
(number of pads/day), PF strength (power and endurance), and measures of QoL (IIQ-7
and UCLA-PCI functional questionnaires) (Appendix H-I)
Statistical analysis included descriptive statistics, t-tests and Chi-square tests for
demographic comparisons. For the retrospective study, the Chi-square test was used to
compare incontinence and the Mann-Whitney test was used to compare the severity of
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incontinence between the 2 groups at the 3 points of time. Each factor was evaluated
using the Chi-square (categorical variables), t-test (normally distributed continuous
variables), or Mann-Whitney (non-normally distributed continuous variables) test to
assess its association with less incontinence post-operatively in both the retrospective and
prospective study. For the cohort study, the variables were further analyzed as a function
of time post-op and PFMT condition in a 3X2 mixed-model Analysis of Variance
(ANOVA). For the variables without a pre-op value, a 2X2 mixed-model ANOVA was
used.
OPERATIONAL DEFINITION OF TERMS
The following definitions are provided to ensure uniformity and understanding of these
terms throughout the study.
Incontinence-involuntary leakage of urine from the bladder.
Intra-operative-occurring, carried out, or encountered during the course of surgery.
PERFECT scheme-Power Endurance Repetitions Fast Every Contraction Timed
grading scale to manually assess the pelvic floor muscle strength and endurance,
using the Oxford scale for the measure of power, number of seconds of
contraction held for endurance, number of repetitions of the contractions.62
Peri-operative-relating to, occurring in, or being the period around the time of a
surgical operation.
Post-operative-relating to, occurring in, or being the period following a surgical
operation.

Pre-operative-occurring, performed, or administered before and usually close to a
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surgical operation.
Quality of Life- the impact of incontinence on quality of life was measured by 2
condition-specific functional assessment questionnaires: the IIQ-7 and UCLAPCI
sEMG-surface electromyography, the electrical activity of individual muscles or
muscle groups is detected and amplified through non-invasive electrodes.
SUMMARY
Prostatectomy remains the treatment of choice to address the presence of prostate CA in
men2. Recently the use of the da Vinci robotic-assisted prostatectomy has become
increasingly popular with surgeons. Despite the technological advances, there has not
been an associated improvement in post-operative complications, with the most common
complication being that of urinary incontinence. A PFMT program may aid in the
recovery of post-operative continence if performed pre-operatively, before the peritoneal
tissues have been damaged. Therefore, this research proposed to identify if a one-time
pre-operative PFMT session aids in limiting the severity and duration of post-operative
incontinence and its effect on quality of life.
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CHAPTER 2: LITERATURE REVIEW
INTRODUCTION
Incontinence following a robotic-assisted radical prostatectomy (RARP) remains as one
of the most common post-operative complications affecting ones quality of life
immediately following surgery.2,12-18 Several factors may influence the occurrence and
severity of post-operative incontinence. Being able to predict these factors may aid in the
treatment decision making process for both the patient and the surgeon through offering
counseling in individualized expected outcomes. Furthermore, identifying the factors
that result in increased severity of incontinence post-operatively may allow for earlier
intervention such as biofeedback and PFMT that may enhance the likelihood of recovery
of continence after the procedure. The following review of selected studies in the field
highlights findings most influential in the development of more advanced surgical
procedures as well as pre-operative, peri-operative, and post-operative events that may
aid in preventing the occurrence of urinary incontinence post-operatively. The review is
organized according to historical events, predictors of the occurrence of urinary
incontinence post-operatively, and research pertaining to the use of PFMT to address
incontinence in men following a prostatectomy.
THE DA VINCI ROBOTIC ASSISTED PROSTATECTOMY
Instrumentation
Laparoscopic surgery for the treatment of prostate CA has been gradually replacing the
more commonly used open retro-pubic approach since the 1990s. However, even though
this minimally invasive technique results in less morbidity (decreased blood loss and
rates of transfusion), the use of the conventional instrumentation remains complex,
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demanding extensive knowledge in the topographical anatomy and proficiency with
endoscopic suturing and intra-corporeal knot tying, which is required in a laparoscopic
radical prostatectomy. The advent of the da Vinci RARP in the early year 2000 s in
America provides for a simpler and more enabling endoscopic technique. The daVinci
Surgical System (Intuitive Surgical, Inc., Sunnyvale,CA, USA) incorporates three robotic
arms, one holding a novel dual channel endoscope and two holding the endoscopic
instruments, which are controlled through manipulation of two master controls mounted
on the surgeon s console, where the surgeon sits and operates during the procedure.
Surgeon manipulation of the controls is managed by a processor that filters, scales and
relays the exact motion of the surgeon s hands and fingers to the endoscopic instruments.
There is no measurable delay between movement of the surgeon controls and the
mirrored movement of the instruments. Tremors and minor insignificant movements of
the surgeon that are commonly encountered while holding instruments, particularly
during protracted procedures, are eliminated by the processor. The integrated architecture
of the instruments and system allow 7 degrees of freedom which is more than allowed by
the human hand. The two images of the dual channel endoscope are fused providing the
surgeon with a magnified, resolute stereovision image of the operative field. The
magnification and manual dexterity offered by the robot allows a higher level of attention
to detail and resultant precision in surgery.
Outcomes
It has been suggested that surgical techniques sufficiently refined to preserve or
reconstruct the perineal structures peri-operatively would lower the chances of side
effects.4-11 Since the advent of the RARP procedure, studies have been conducted to
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compare the outcomes between the various surgical procedures in an attempt to identify a
superior technique. The outcomes measured included those of positive surgical margins
and PSA levels as well as physical and mental functioning, urinary continence, potency,
and quality of life. All have come to the same conclusion: despite the improved
microsurgical precision offered by the RARP to preserve the integrity of the PF
structures, the functional and oncological outcomes remain similar between the
techniques11-17. However, the RARP does offer the benefits of a minimally invasive
technique notably that of decreased blood loss and transfusion rates, decreased postoperative pain, shorter convalescence, and better cosmetics.11,14-17,64-67 Thus, urinary
incontinence remains the main post-operative complication affecting men following a
daVinci RARP and it has therefore become important to attempt to identify the factors
that may influence its occurrence.
Types of incontinence
There are different types of urinary incontinence, including stress, urgency, or mixed.
Stress urinary incontinence refers to the involuntary loss of urine with physical exertion
that is the result of anatomical defects in the structures that support the bladder and
urethra, while urgency urinary incontinence is associated with the involuntary loss of
urine due to a sudden compelling need to void that is due to the contraction of the
detrusor muscle, and mixed urinary incontinence presents with signs of both stress and
urgency urinary incontinence. The type of urinary incontinence most commonly found in
men following a prostatectomy is that of stress urinary incontinence.68,69The degree of
incontinence can range from mild to severe, where men experience the loss of urine with
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changes of positions such as sitting from lying, or standing from sitting, coughing, during
physical activities such as lifting or bending, or even at rest.
RISK FACTORS OF INCONTINENCE
Long term
Most studies that have been conducted to identify the factors that predict recovery of
continence long-term, have primarily looked at age and surgical procedures. In a large
scale study that included functional questionnaires, Shikanov et al70 reported on 1436
patients who underwent RARP and found that younger age (<70) and higher urinary and
sexual function pre-surgically were associated with continence at 1 year post-surgically.
A similar analysis by Barnoiv et al19 found in addition that prostate volume, nerve
sparing status, and 24 hour urine loss at 1 month post-operatively also predict the risk of
urinary incontinence at 1 year with good accuracy. Choi et al4 studied the same factors as
well as bladder neck sparing and found that bilateral nerve sparing and bladder neck
sparing techniques, and higher urinary function pre-operatively resulted in improved
urinary control up to 2 years post-operatively. On a smaller scale, Hakimi et al71 assessed
anatomical measurements through endorectal MRI on 75 patients and found that longer
urethral length, as well as younger age, lower BMI, higher pre-operative urinary function,
and smaller prostate volume correlated to a faster return of continence. Kaye et al6
further assessed the effect of nerve sparing on quality of life and found better outcomes at
12 months with uni- or bilateral nerve sparing, younger age and lower BMI. Conversely,
in another large study that assessed the functional outcome of both open procedure and
RARP, Nilsson et al72 did not find that BMI, prostate weight, or comorbidities had an
effect on the prevalence of urinary incontinence at a 2 year follow-up. While Novara et
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al73 agree that no variables related to prostate CA correlated with urinary incontinence in
their study, they did find that age and comorbidity index were factors independently
predictive of continence recovery at 1 year post-operatively.
Short term
Urinary incontinence usually resolves naturally by the end of the first year following any
type of prostatectomy, with individual studies reporting up to 97% continence rate after
RARP.48,49 Therefore, it would seem more advantageous to identify predictors geared at
shortening the time to recovery of continence following RARP. Only a small number of
studies have been done to examine the factors that may predict recovery within 3 months,
especially after RARP. A small study by Potdevin et al8 compared the inter- and intrafacial nerve sparing techniques on functional and oncological outcomes and found that
the intra-facial technique improved potency rate and shortened the time to return of
continence, however to the detriment of higher rates of positive surgical margins. A
much larger study by Srivastava et al74 also found early return of continence with no pad
use at 12 weeks when a higher degree of nerve sparing technique was used. In a
retrospective study, Kim et al75 identified that age (<70), higher pre-operative sexual
health, lower clinical T-stage, lower Gleason score, shorter operative time, lower blood
loss, and smaller prostate volume are all associated with urinary recovery within 3
months. However, in a large prospective study on 1299 patients from a high volume
center, Ko et al20 demonstrated that only age and nerve sparing were factors for
continence by 3 months. Lee et al22 found that only age was associated with early
recovery of continence at 6 weeks after adjusting for confounding factors in a
multivariate logistic model, but the study was small with limited factors (BMI, IPSS
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score, nerve sparing). In a large restrospective study spanning over 10 years (from 2003
to 2013), Palisaar et al76 analyzed predictors of short-term recovery of continence at 6
weeks in both the open and RARP. The multivariate results showed that nerve sparing,
clinical T-stage, the surgeon s experience, and duration of catheri ation were all
independent factors. A recent research conducted by Lavigueur-Blouin et al21 observed
pre-operative predictors of pad-free continence recovery at the first follow-up visit one
month after RARP and reported a rate of 44% pad-free patients. In their multivariate
regression analysis, age and ICIQ (International Consultation on Incontinence
Questionnaire) were the independent predictors of urinary continence at one month.
Other variables, including BMI, PSA, SHIM (Sexual Health Inventory for Men) score,
prostate weight, and type of nerve sparing were not statistically significant predictors of
very early continence. By contrast, in a large study of more than 1200 patients followed
retrospectively, Sammon et al77 concluded that bilateral nerve sparing and the placement
of a supra-pubic tube for bladder drainage were predictors of not requiring a pad
immediately post-operatively.
Finally, even though some studies seem to contradict each other, a consensus panel78 was
conducted in 2012, and following systematic reviews and a meta-analysis, concluded that
the following factors that generally contribute to increased risk of post- RARP
incontinence are: age, obesity, short membranous urethral length, anastomotic strictures,
low surgeon experience, non-nerve sparing techniques, non-bladder neck preservation,
and high prostate volume.
All the aforementioned studies have been able to identify patient characteristics and
procedural techniques as predicting factors to the incidence of urinary incontinence post-
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operatively. None have looked at PF strength as a possible factor. One of the aims of
this study is to identify whether PF strength is a predictor and whether improved strength
results in improved continence immediately post-operatively.
PELVIC FLOOR
Anatomy
A recent research report conducted by Gorniak and Conrad 79 has compiled the
descriptions in the literature with dissections to re-examine the anatomy and functional
interactions of the muscles of the pelvic floor, as well as the endopelvic and visceral
support structures. The diamond-shaped perineum is bound anteriorly by the pubic
symphysis, posteriorly by the tip of the coccyx, laterally by the pubic arch, ischial
tuberosities, and sacrotuberous ligaments, and cranially by the pelvic diaphragm (Figure
2.1). The pelvic diaphragm is part of the pelvic floor musculature and consists of the
levator ani (formed by the pubococcygeus and the iliococcygeus) and the coccygeus
muscles, and provides support for the pelvic viscera. The superficial and deep transverse
perineal muscles, bulbospongiosus, levator prostate, and outer layer of the external anal
sphincter attach to the perineal body which is centrally located. The perineum is
generally divided into a posterior anal triangle and an anterior urogenital triangle by a
line passing through the ischial tuberosities and the perineal body (Figure 2.2). The anal
triangle is bordered laterally by the obturator internus muscle and its fascia connecting to
the levator ani through the tendinous arch which runs from the pubic body to the ischial
spines and is formed by fibers of both muscles. The inferior part of the obturator internus
fascia splits to form the pudendal canal through which the pudendal nerve and internal
pudendal artery and vein runs through. The urogenital triangle is further divided into the
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superficial and deep perineal spaces. The superficial transverse perineal,
bulbospongiosus, and ischiocavernosus muscles lie in the superficial space, while the
deep perineal space consists of the external sphincter urethrae, the compressor urethrae
and the deep transverse perineal muscles. The urethra passes through this urogenital
diaphragm.

Figure 2.1 Perineum boundaries
Figure 2.2 Pelvic floor muscles
Reprinted with permission from Elsevier. Copyright 2012
Further providing support to the viscera is the endopelvic fascia that is commonly
described as either visceral or parietal fascia. The visceral fascia connects organs to the
pelvic wall and to each other as ligaments. It may contain neurovascular bundles
embedded in the loose connective tissue. Parietal fascia consists mainly of dense
connective tissue associated with the pelvic wall (tendinous arches).
Proper pelvic function requires a balanced interaction between the muscles of the pelvic
floor and the supporting connective tissue elements. Maintaining an upward and forward
position of the bladder is important for urinary continence. In males, the prostate,
urogenital diaphragm, perineal membrane, and bulb of the penis lie stacked like a column
caudal to the base of the bladder. This column and the associated ligaments act to
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mechanically hold the bladder upward (Figure 2.3). Contraction of the levator ani moves
the bladder superior and anterior to allow bladder filling. It also elevates the pelvic
diaphragm in response to an increase in abdominal pressure. The anterior movement of
the bladder changes the angle of the bladder neck to crimp off the urethra thereby
preventing flow. Relaxation of the levator ani allows the organs to depress and move
posteriorly resulting in urination. Dysfunction of any part of this unit that results in a
change in the mobility of the pelvic organs, compromises neurovascular structures,
and/or causes postural changes, such as may occur following surgical procedures may
increase the chances and severity of urinary incontinence.

Figures 2.3 Male urogenital system
Reprinted with permission from Elsevier. Copyright 2012

PFMT in females
While no study has identified PF weakness as a predictor of urinary incontinence in male
patients following prostatectomy, extensive research has been conducted on women to
demonstrate the effect of a PFMT program in the prevention and treatment of urinary
incontinence following childbirth and uro-gynecological procedures. It has become
16

mainstay as a conservative management option since Arnold Kegel documented on the
successful treatment of female stress urinary incontinence with the use of pelvic muscle
exercises with biofeedback perineometer in 1948.80 Several Cochrane systematic reviews
have investigated the benefits of PFMT in improving continence in women, however, the
analyses remain inconclusive whether PFMT is better than other therapies (biofeedback,
cones, electric stimulation, behavioral), drugs (anticholinergics), or surgeries (slings,
colposuspension).26,81,82 A recently updated review by Dumoulin et al83 studied whether
PFMT is an effective treatment in the management of female urinary incontinence
compared to no treatment, placebo, sham, or control treatments. The review provided
support for the widespread recommendations of PFMT as a first line strategy in the
conservative management of urinary incontinence. Compared to the control group
women treated with PFMT leaked less frequently and of smaller amount with the benefits
persisting up to one year after treatment. In view of these results, Bo et al84 studied the
role of PFMT and were able to support a biological rationale verified by ultrasonographic
and magnetic resonance imaging. They were able to provide two rationales: firstly that
an intentional PF contraction clamps the urethra, thereby increasing the urethral pressure,
and secondly that a stronger PF tone provided improved bladder neck support, thereby
limiting its downward movement during an increase in intra-abdominal pressure (such as
a cough or physical exertion), which in turn prevents urine leakage. Additional studies
have shown increased PF strength and tone in continent vs. incontinent women,85-88 and
improved PF strength and tone in incontinent women following PFMT with resultant
improvements in urinary incontinence.89-96
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PFMT in males post-op
As a result of the above growing body of evidence pointing to the benefits of PFMT to
address urinary incontinence in women, PFMT has also more recently emerged as a
conservative treatment option to address male incontinence. Individual studies have
found modest benefits of PFMT with or without biofeedback in improving urinary
incontinence following radical prostatectomy. One study of 300 men compared early
PFMT without biofeedback initiated prior to discharge to no training.97 The authors
found that PFMT significantly reduced the time to recover continence with improvements
noted at 1, 3 and 6 months following prostatectomy. Continence was assessed using the
1-hour and 24-hour pad tests and defined as the use of no or one pad per day. At 3
months, continence was achieved in 74% of men in the treated group vs. 30% in the
control group. The difference declined at 6 months and by 12 months was no longer
significant. Other studies assessed PFMT with biofeedback compared to no training or
usual care.47,98,99 A study by Van Kampen et al47 showed the highest success rate. The
PFMT program consisted of individual treatment sessions once a week while the control
group received sham treatments. Continence was defined as <2 grams urine loss on a 24hour pad test. At 3 months after surgery 88% of the men in the PFMT group were
continent compared to 56% in the control group. After one year the difference reduced
with 95% and 79% of men continent in the treatment group vs. control group
respectively. This finding seems to indicate the effect of PFMT decreases over time. It
concurs with reviews showing that the urinary symptoms following radical prostatectomy
tended to improve over time regardless of conservative management of any type for postprostatectomy urinary incontinence.36,49

18

Only two studies41,100 investigated and found a physiotherapist guided PFMT to be
beneficial in the recovery in continence following prostatectomy when compared to a
home written/verbal PFMT program. Other research studies have reported no significant
difference between treatments for any outcomes at any of the evaluated times,33,35,101
however, all groups effectively reduced their urine loss after 12 weeks of treatment. The
study by Overgard et al102 found no difference between groups at 3 months, but when
PFMT continued up to one year after surgery, the improvements became apparent at the 6
month and 12 month time with 92% continent vs. 72% in the control group by 12 months.
The study suggested that physiotherapist guided PFMT enhanced long term adherence to
PF exercises thereby improving continence rates over time more than information
provided to patients for training on their own.
The latest Cochrane Collaboration report conducted by Campbell et al48 on 37 trials
cautioned the individual results, stating that the trials were of poor to moderate quality.
They found that the trials were too heterogeneous in variation in the timing, type, and
intensity of the PFMT and definition of continence, rendering conclusive and definite
evidence difficult. The review included trials in which men also received treatment
before surgery and also included trials using biofeedback which were considered together
with those without biofeedback. A systematic review by MacDonald et al103 updates the
findings of the Cochrane review by focusing solely on PFMT post-prostatectomy. They
considered biofeedback enhancement as a separate treatment method. Their analysis
found that 57% of subjects receiving PFMT achieved continence or were without
continual leakage within two months compared to 37% of control subjects. Within 3-4
months there were no significant differences in rates of continence between the two
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groups. Furthermore, biofeedback enhanced PFMT was no more effective than oral or
written PFMT instructions. Davie et al31 in their review of 14 randomized controlled
trials and 7 systematic reviews concurred that the current evidence demonstrates that the
recovery time of continence can be shortened with PFMT. Therefore, studies that have
looked at the various treatment options in the management of post-prostatectomy urinary
incontinence, usually strongly recommend non-invasive therapies such as PFMT (with or
without biofeedback and/or electric stimulation) for mild to moderate incontinence in the
early months post-operatively, as well as the addition of pharmacological therapy for
early success. They further suggest surgical therapies to be considered only if
conservative therapy fails, if the incontinence is severe, or if it persists beyond 12 months
post-operatively.29,30,63,104
PFMT in males pre-op
Investigators sought to explore whether pre-operative PFMT provided additional benefit
in continence recovery in the early stages following prostatectomy. One observational
study compared the effects of the pre-operative physiotherapist guided PFMT versus
verbal instructions by the surgeon when it was provided at least 4 weeks prior to the
surgical intervention.54 The study found that the physiotherapist guided PFMT
participants were drier at 6 weeks compared to those receiving instructions by the
surgeon, but the effect disappeared by 3 months. Others have shown that there is no
advantage of biofeedback over verbal instructions alone when the pre-operative PFMT
was initiated 2-4 weeks prior to surgery.57,105,106 A RCT of 180 men conducted by
Geraerts et al107 compared the treatment group who received PFMT weekly for 3 weeks
pre-operatively to a control group receiving post-operative PFMT. The PFMT consisted
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of a 30 min therapist guided program with instructions to perform 60 contractions a day
at home. Continence was defined as 3 consecutive days at 0 gr of urine loss on a 24 hour
pad test. The results showed that both groups recovered continence to the same extent
when assessed at the 1, 3, 6 and 12 month time points. These studies did not find that preoperative PFMT aided in the recovery of urinary incontinence following prostatectomy as
none were able to show better outcomes for the patients who started PFMT preoperatively compared to those who started post-operatively.
A systematic review conducted by Nahon et al53 found that 9 studies were of good to
moderate quality, but found only 4 studies could conclusively attest to decreased time to
continence and severity of incontinence when a PFMT program was offered preoperatively. Other systematic reviews have been able to conclude that a pre-op PFMT
program improves early continence as well as QoL, but not long term continence
rates.108,109 A small non-randomized study compared several weeks of pre-operative
PFMT with biofeedback to post-operative PFMT and showed faster return of continence
in the pre-operative group at 6 weeks post-operatively.55 However, the sample size of 8
subjects per group was too small for the author to draw conclusions with inferential
statistics. Parekh et al43 also found early return of continence with pre-operative PFMT,
but the difference converged and was no longer statistically significant by 12 months.
The same observation has been noted in other larger randomized control trials.
Centemero et al110 investigated the effect of a PFMT initiated 30 days prior to
prostatectomy. Their PFMT program involved a 30-min therapist guided session twice a
week. Continence was defined as no leaking as reported in a bladder diary. They found
that pre-operative PFMT improved early continence and QoL measures at the 1 and 3
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month follow-up times with rates of continence at 3 months of 59.3% in the treatment
group vs. 37.3% in the control group. Two other studies used bladder diary as the
primary outcome for measure of continence, and QoL questionnaires as the secondary
outcome. Burgio et al111 found that pre-operative PFMT hastens the recovery of urinary
control and diminishes the severity and impact of incontinence when the PFMT was
provided in a single biofeedback session 2-4 weeks prior to surgery compared to standard
care. In a similar study, Tienforti et al56 arrived to the same conclusion when the preoperative PFMT session was provided one day prior to surgery. Both studies showed that
the decreased incidence, duration, and severity of urinary incontinence lasted until the 6
months follow-up.
Wang et al58 performed a meta-analysis in an attempt to clarify the controversial issue of
whether additional pre-operative PFMT would hasten the resolution of urinary
incontinence after prostatectomy. They found that only 5 studies were deemed of
sufficient quality to qualify for inclusion in their analysis. They found that the studies
were able to report higher patient satisfaction and smaller impact of incontinence on QoL
in the pre-operative groups. However, the pooled analysis suggested no benefit on
continence rates from the additional PFMT pre-operatively at the 1, 3, 6, and 12 month
time points. They theorize that the lack of conclusive evidence may be due to
heterogeneous pre-operative PFMT regimen (from 4 times to 30 minutes a day) and
timing of initiation of the pre-operative PFMT (from one day to 4 weeks pre-surgery) in
each study. Furthermore, the discrepancy between the positive and negative studies has
been suggested to lie in the choice of the primary outcome in defining continence. The
study by Geraert et al107 adhered to a higher standard definition of continence using pad
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weight. While pad tests are considered to be objective measures, patients may change
their activity levels to prevent leakage, thus influencing the results. Most studies that
found an advantage to the addition of a pre-operative PFMT defined continence as no
urinary leaking reported in a patient completed bladder diary. Possibly incorporating an
element of patient perception in the outcome assessment may be more relevant to the
clinical scenario. Another factor that may explain the discrepancy is the type of
intervention given to the control groups. In the studies with negative findings, control
patients received a more intensive regimen of PFMT through written/verbal instructions
which is different than standard or no care, and thus may also have impacted the results.
One could speculate that even a low tech pre-operative PFMT can improve the outcomes.
In view of these results further research is needed to elucidate optimal treatment regimen,
duration and timing of PFMT pre-operatively, as well as definition of continence in order
to obtain maximal urinary recovery.
PF strength assessment
PF muscle strength is most commonly quantified in clinical practice through manual
muscle testing or digital palpation using the modified Oxford and PERFECT scales,
through use of a perineometer which measures changes in pressure, or through
electromyography (EMG) which measures the activity of the muscle. Digital palpation
and the use of a perineometer were first described by Kegel80 as methods to evaluate
pelvic floor muscle function. In women digital palpation involves placing a finger in the
distal vagina and asking the patient to squeeze around the finger and lift inward.
Whereas perineometer consists of a pneumatic device inserted vaginally that measures
the pressure in mmHg performed by a pelvic floor muscle contraction. For males the
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assessment is done via the anal canal. The examination per anum has been found to be a
reproducible test of pelvic floor muscle function in men.112 The modified Oxford scale is
a 6-point scale where 0 = no discernible PFM contraction; 1 = flicker, or pulsing under
the examining finger, a very weak contraction; 2 = a weak contraction, an increase in
tension in the muscle without any discernible lift or squeeze; 3 = a moderate contraction
characterized by a degree of lifting of the posterior pelvic wall and squeezing on the base
of the finger with in-drawing of the perineum; 4 = a good PFM contraction producing
elevation of the posterior pelvic wall against resistance and in-drawing of the perineum; 5
= a strong contraction of the PFM; strong resistance can be given against elevation of the
posterior pelvic wall.60 PERFECT is an acronym with P = power (the measure of
strength), E = endurance (timed maximum contraction held in seconds), R = repetitions,
F = fast contractions, and finally ECT = every contraction timed.61 Both scales have been
validated in women and found to have high reliability and reproducibility by the
developers.61 A significant correlation was found between muscle strength measured
using the Oxford grading scale and lift measured by finger palpation (r = 0.86; p = .03)
and muscle strength and perineometric pressure (r = 0.79; p = .001). Interrater reliability
for power (r = 0.95; p < .001), endurance (r = 0.95; p < .001), repetitions (r = 0.73; p <
.005), and number of fast contractions (r = 0.91; p < .001) were all good to excellent.
Intrarater reliability was also excellent for power (r = 0.93; p < .001) and endurance (r =
0.99; p < .001). Digital palpation as a measuring tool for pelvic floor muscle strength has
also shown high intra-observer rates of reproducibility, but low inter-examiner rates. Bo
et al found a Cohen s kappa value of only 0.37 even amongst highly trained
physiotherapists.113 These findings were confirmed by several other authors.114-116 By
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contrast sEMG does not provide a direct measure of strength, but rather measures the
electrical activity of the muscle.59 In clinical practice surface electrodes placed over the
perineum or vaginally or rectally are most commonly used. Gunnarsson et al117 have
shown that PF muscle activity can be measured reliably with sEMG, and Glazer et al118
also found sEMG with strong clinical predictive validity in determining PF related
disorders including incontinence. Furthermore, studies have found moderate correlation
(r = 0.63; p < .05) between the digital palpation and sEMG activity.119,120 Bo et al59
concluded that the PF squeeze and lift of a contraction can be most reliably tested with
digital palpation, while other measures of muscle function such as endurance and
repetition are better tested with sEMG. Both tools can be used to assess different aspects
of PF muscle function when assessed by a single examiner. Since a perineometer device
was not available to the investigator, digital palpation was used to assess PF
strength/power, while sEMG served to determine measurements of endurance (maximum
contraction held in seconds and number of repetitions at maximum contraction).
PF strength as an outcome measure
Many studies that have shown an improvement rate in the recovery of urinary
incontinence following prostatectomy have also included a measure of PF strength in
their outcomes. Rajkowska-Labon et al45 used surface EMG to record the activity of the
muscle during a contraction, and found that only the response time, not the amplitude,
showed a statistically significant difference in men who received a post-op PFMT
program compared to men who did not, possibly indicating improved neuromuscular
coordination. Ribeiro et al99 showed an improvement in strength using the Oxford scale
while Rigatti et al50 showed an increase in perineometric measures in subjects who had
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received PFMT. The improved thickness of the PF muscles measured through magnetic
resonance imaging by Song et al51 correlated with improved continence at 3 months.
Finally, Ocampo-Trujillo et al52 subjected their participants to an intense pre-operative
PFMT program consisting of supervised PFMT 3 times per day for 4 weeks. They were
able to observe changes in the histomorphology of the PF muscles with an increase in the
cross-sectional area of the muscle fibers, as well as higher pressures on perineometer,
which correlated with improved continence post-operatively.
These findings support the objectives of a PFMT program geared to improve the timing
of a PF contraction, strength, endurance, and tone of the PF muscles, thereby increasing
urethral pressure and limiting the downward movement of the bladder neck, thus
preventing urinary leaking. However, only two studies reporting on pre-operative PFMT
included patients with RARP and all studies reporting on the use of PFMT postoperatively were conducted following the traditional open prostatectomy. Only one study
compared the use of PFMT post-operatively between the open and RARP. Geraerts et
al121 found that the patients who had undergone RARP regained continence sooner and
scored significantly better on QoL surveys at 1 and 3 months post-operatively.
PFMT protocols
There are different types of PFMT. The PF muscles consist of 70% type I slow twitch
and 30% type II fast twitch muscle fibers, with a general ratio of 2:1.79 The slow twitch
fibers can contract for a long period of time at a low force, whereas the fast twitch
contract for a shorter time but can generate more force than the slow twitch. The
prominence of the slow twitch fibers in the levator ani enable it to support the pelvic
viscera and hold the anorectal junction sphincter closed for a long period of time.
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However, a quick contraction of the PF may be required such as with a sudden increase
in abdominal pressure. Therefore, it is important to integrate training to strengthen both
types of fibers. Characteristic features of strength training include low numbers of
repetitions with high loads which can be achieved by increasing the amount of voluntary
effort with each contraction and by performing the exercise first with (lying) then against
gravity (sitting, standing). Endurance training is characterized by high number of
repetitions or by prolonged contraction with low to moderate loads. Currently there is no
standard PFMT protocol. The women s health section of the APTA provides guidelines,
which combines the above characteristics. Furthermore, no difference was found whether
patients received several health care professional guided sessions54,110 versus one55,56,111
and doing the PF muscles exercises on their own. 105 Therefore, this study aimed at
providing additional insight in the benefits of a single session of pre-operative PFMT for
those patients whose prostate CA was surgically removed through robotic-assisted
technology.
Quality of Life
In general most men will experience some level of UI in the first few weeks to months
following radical prostatectomy. Urinary incontinence following prostatectomy has been
reported by patients to negatively affect their quality of life (QoL). 29 The incidence of UI
post-prostatectomy varies between 0.8% and 87% in the first 3 to 6 months and between
5% and 87% after one year.36,40,99 The study by Sanda et al122 on QoL showed that UI
provided the highest increase level of distress post-op. Studies that have looked at
incidence of UI and bother on QoL long term note an impact on men s self-esteem,
perception of own health, and impact on their existence, delaying return to work and/or
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usual physical and social activities at one year post-op123-125 and even onwards to 2 years
post-op.126,127 Incontinence has also been found to be associated with feelings of
embarrassment, anxiety and fears of not being cured, and reduced confidence. 128
In studies that have looked whether post-op PFMT improved QoL scores only two
studies53,100 reported that post-op PFMT improved function and incontinence post-op but
no difference in QoL parameters compared to their control group was found. However,
the many other studies46,51,97,98,99,101,129-131 found a correlation between UI and QoL with
noted decreased continence recovery time being associated with lesser impact on men s
lives in the post-op PFMT groups. The few studies56,107,108,132 that also included pre-op
PFMT showed men gave a significantly better self-report on QoL up to 6 months postop. One of the aims of this study was to explore whether a single PFMT session pre-op
would aid in improving QoL measures at the early stages post-op.
Functional Outcomes
The impact of urinary incontinence can be assessed through health-related QoL
(HRQOL) patient-reported outcome measures. HRQOL addresses the entire spectrum of
human experience, including daily necessities, interpersonal relationships, physical and
mental health, illness, and professional and personal happiness. There are a variety of
HRQOL available. The questionnaires chosen for this study are the UCLA-PCI (UCLAProstate Cancer Index) and the IIQ-7 (Incontinence Impact Questionnaire) because they
more specifically address the symptom of incontinence. The short forms have been
selected because they are more practical in a clinical setting and less burdensome on the
patient.
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The UCLA-PCI is a self-administered, multi-item disease specific instrument developed
to capture the health concerns central to the QoL of men treated for prostate CA.133 The
questionnaire consists of 3- to 6- point Lickert scales containing 15-disease targeted items
that address impairment in the urinary, bowel, and sexual domains. The psychometric
properties have been found to be good with test-retest reliability ICC ranging from 0.66
to 0.92 and internal consistency Cronbach

ranging from 0.65 to 0.93. It is scored from

0 to 100 with higher scores representing better function and less bothered by
incontinence.
The IIQ-7 is a condition specific instrument which was originally designed to assess
HRQOL of middle aged and older women suffering from urinary incontinence. 134 Moore
et al135 determined that the IIQ-7 can also be used reliably with men. The content
validity index was 0.88 and internal consistency ranged between 0.88 and 0.92.
Furthermore, a positive relationship was found between grams of urine loss on a 24 hpad test and IIQ-7 scores (r = 0.34; p = .003 to r = 0.51; p = .001). The domains include
measures of physical activity, social relationships, travel, and emotional health with
scores ranging from 0 to 100. When the IIQ-7 scores decreased, self-reported QoL
improved.
CONTRIBUTION OF THE STUDY
Urinary incontinence post-operatively is one of the main fears of men who are
undergoing a prostatectomy due to its impact on their QoL. 29 Health care providers who
want to help their patients in dealing with the issues associated with urinary incontinence
may be interested in simple techniques which may improve its management. If it is
shown that a pre-operative PFMT session aids in reducing the severity of incontinence,
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more urologists and oncologists may want to refer their patients who will undergo a
radical prostatectomy for PFMT. Physicians who may want to refer their clients preoperatively to prevent post-operative urinary leakage, may seek providers who perform
PFMT within their region. Furthermore, men who choose to undergo a radical
prostatectomy are aware of the possible post-operative complication of urinary
incontinence and its consequences, and may request pre-operative PFMT in a proactive
manner.
Pelvic floor assessment is considered within the scope of practice for physical therapists
in all State s Practice Acts.136 However, only a small portion of physical therapists
pursue the specialization of pelvic health which includes the assessment and treatment of
PF dysfunction. The few that are, may not all treat men, rendering access to qualified
therapists difficult. However, more therapists may want to add PFMT to their services if
its benefits are shown, thereby improving the availability of qualified providers.
Therefore, the results of this research may further promote the benefits of a pre-operative
PFMT session in the prevention of post prostatectomy urinary incontinence. If it is
indeed shown that a one-time, physical therapist guided PFMT session pre-operatively
reduces the severity and duration of post-operative urinary incontinence following a da
Vinci prostatectomy, more men might avoid having to manage the consequences of
incontinence, saving them from embarrassment and cost.
Through improved awareness, more therapists may be inclined to pursue this aspect of
interventions, and both patients and physicians would seek providers to minimize this
post-operative complication. Developed awareness and improved access to the service
would enable more men to receive this one-time pre-operative training. This would save
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on cost induced post-operatively to deal with the consequences of urinary incontinence,
and improve men s post-operative quality of life more expediently.
SUMMARY
RARP is becoming the treatment of choice to address prostate CA in men. However,
despite the advanced technology, minimal invasive technique, and improved dexterity
that allow for limited damage to the perineal structures during surgery, the post-operative
complication of urinary incontinence remains unchanged compared to the traditional
approaches. Researchers have been able to identify risk factors that may contribute to
improved recovery of urinary incontinence post-operatively. However, none of the
factors observed in the studies included PF weakness pre-operatively. Improved PF
integrity and strength has been shown to improve or reduce the severity and duration of
urinary incontinence and its impact on QoL in the early stages when a PFMT was offered
post-operatively. It is unclear whether offering pre-operative PFMT has additional
benefits. No advantage was found whether the PFMT was performed over a course of
several sessions compared to one, or whether the PFMT was supervised compared to
done at home. Furthermore, the results of the current literature stem primarily from
studies of PFMT and open prostatectomy procedure, while studies of PFMT and RARP
are scarce.
Therefore, this study aimed at identifying the possible benefits of a one-time preoperative PFMT session on patients undergoing a RARP. Whether, the PFMT aids in
limiting the severity and duration of post-op urinary incontinence, its effect on QoL, and
whether PF strength is a predictor.
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CHAPTER 3: METHODOLOGY
INTRODUCTION
The first portion of this study was a retrospective analysis with the primary objectives
being that of identifying whether men who received the one session of pre-operative
PFMT have symptoms of post-operative urinary incontinence to a lesser degree than
those who did not, and whether certain variables such as pre-operative PF strength may
predict better outcomes. The second portion of the study consisted of a small prospective
cohort study to validate the factors identified in the retrospective study. The rationale for
this approach is that the first portion provided a more general picture of the research
problem, while the analysis of the second portion refined and explained the results further
by exploring individual subjects in more depth.
RETROSPECTIVE STUDY
Research Method
Phase 1 of this study employed a retrospective design to compare adult males who
received the pre-operative PFMT and those who did not. Age, BMI, PSA, Gleason score,
clinical T-stage, PF strength and endurance, and a post-operative measure of continence
recovery defined as the number of pads used were recorded. These were compared
between the 2 groups to answer the questions of this research:
-

Do men who receive a one-time PFMT have less incontinence following
the robotic assisted daVinci prostatectomy than men who do not?

-

What are the differences in PF muscle strength and demographic variables
between patients with more vs. fewer incidence of urinary incontinence?
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Subjects
Records were collected from the Jefferson Surgical Clinic (letter of support Appendix A)
where two physicians routinely perform the da Vinci robotic assisted prostatectomy
procedure, as well as from the investigator who is a physical therapist working at Back to
Basics Family Physical Therapy, an outpatient private practice. Both clinics are located in
Roanoke, VA. Dr. Hayes and Dr. Daniel are board-certified urologists with 18 years and
13 years of experience respectively, in the daVinci prostatectomy procedure. They have
refined their surgical technique as more evidence-based research has become available
through the years. The electronic charts from consecutive patients who have undergone
the surgical procedure with and without the pre-operative PFMT session between
1/1/2008 and 12/31/2016 were retrieved by the secretaries from both offices and
reviewed by the investigator at the physicians office. To ensure the privacy and
confidentiality of patient related data, the investigator employed a sequential numeric
coding system that eliminates the ability to identify participants directly from the research
records. Access to the computer dataset was password protected and limited to the
primary investigator. The investigator was solely responsible for the maintenance of the
research records which were secured in a locked cabinet. Records from men between the
ages of 50 and 80 years old were included. The records were excluded if there was not
sufficient post-operative information on the patients regarding their incontinence status,
or if there were intra-operative complications (nerve, rectal, or ureteral injuries, or
hemorrhage), or post-operative complications (PE, DVT, MI, wound infection).
Based on the works of Centemero 107 et al and Ocampo-Trujillo53 et al, the sample size
calculator tool nQuery137 was used to estimate sample size. The results indicated that a
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minimum sample of 70 subjects per group was needed to achieve 80% statistical power.
Data collection was performed until the minimal number of subjects required per group
was reached.
Procedure
Most variables were collected from electronic chart reviews of the patients who have
undergone the da Vinci robotic prostatectomy. For those who had also completed a onetime pre-operative PFMT session, data was also retrieved from the physical therapist s
records.
The pre-operative demographic information was recorded, including: age, BMI, ethnicity,
level of education, symptoms if any, and stage of prostate CA (Gleason score and clinical
T-stage), as well as PF strength (power 1-5/5) and endurance (number of repetitions and
seconds hold) from those patients who had received the one-time pre-operative PFMT by
the physical therapist. Intra-operative factors, such as bladder neck and neurovascular
bundle preservation was also noted. Post-operative information was collected at 3 points
in time: at the post-op follow-up appointments with the surgeon at 6 weeks, 3 months,
and one year following the prostatectomy (Figure 3.1 flow diagram). Incidence (yes/no)
and level of urinary incontinence (number of pads/day) was recorded. Additional
information such as other post-operative complications, need of post-operative physical
therapy, or whether further intervention was recommended or performed was also
gathered (retrospective data collection form Appendix B)
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Figure 3.1: Retrospective study flow diagram

Data Analysis
Descriptive analyses include central tendency (mean, median) and variability (standard
deviation, range, and percentage) were used. The t-test for continuous data and Chisquare test for nominal data was used for comparisons between the two groups.
Furthermore, the Chi-square test was used to compare incontinence and the MannWhitney test was used to compare the severity of incontinence (number of pads/day)
between the 2 groups (Table 3.1). Each factor was evaluated using the Chi-square
(categorical variables), t-test (normally distributed continuous variables), or MannWhitney (non-normally distributed continuous variables) test to assess its association
with less incontinence post-operatively. Additionally, PFM strength (1-5/5) and
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endurance (1-10 secs and 1-10 repetitions) were analyzed within the PFMT group to
assess whether a weaker PFM is a factor in the severity of post-op incontinence.
The statistical analyses were conducted using the Statistical Package of Social Sciences
software (SPSS, version 18.0). The significance level was set at the 0.05 level using a
two-tailed test for all hypotheses.
Table 3.1 Variables and type
Age (years)
BMI (kg/m²)
Ethnicity
Level of education
Symptoms pre-op(Y/N)
PSA (ng/ml)
Gleason Score(2-10)
Clinical T-stage(I-IV)
PF muscle strength(0-5/5)
PF muscle endurance(1-10
secs and 1-10 reps)
Bladder neck preserved
(Y/N)
NVB preserved (Y/N)
Post-op UI(Y/N)
Severity (#of pads/day)

Time intervals

continuous
ordinal
categorical (4 categories - White Black Hispanic Other)
categorical (4 levels) Elementary High-school College
Post-graduate
categorical (2 levels)
continuous
ordinal
ordinal (4 levels)
categorical (3 levels) Poor=0-1, Fair=2-3, Good= 4-5
continuous, but will be interpreted on a categorical scale
(3levels) Poor=1-3, Fair=4-6, Good=7- 10
categorical (2 levels)
categorical (2 levels)
categorical (2 levels)
continuous, but will be interpreted on a categorical scale
(4 levels)
where 0= no UI, 1-2=mild UI, 3-4=moderate UI,
5=severe UI
6 weeks
3 months
12 months

PROSPECTIVE STUDY
Research Method
Phase 2 of this study was designed to compare two groups of subjects through a small
prospective randomized pilot study. The independent variable is the grouping: a sample
of adult males who did not receive the pre-operative PFMT and a sample of adult males
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who received the pre-operative PFMT. The dependent variables were the measures of PF
strength/endurance, severity of incontinence as measured by number of pads used, and
the impact of incontinence on the patient s QoL through the condition-specific IIQ-7 and
UCLA-PCI questionnaires. These were compared between the 2 groups at 6 weeks and 3
months post-operatively to answer the following research questions:
-

Do men who present with the predictive factors identified in the
retrospective study have less symptoms of incontinence following the
robotic assisted daVinci prostatectomy vs. those who do not?

-

Do men who have received the one-time pre-op PFMT session present
with improved PF strength, less incontinence, and better quality of life
scores in the early stages following the robotic assisted daVinci
prostatectomy compared to those who did not?

Subjects
For the prospective study, 20 consecutive patients who were scheduled to undergo RARP
in 2017-2018 by Dr. Daniel from the Jefferson Surgical Clinic in Roanoke, VA were
recruited. Inclusion criteria were men between the ages of 50 and 80 years old. In order
to reduce the risks of any misunderstanding with the instructions given by the researcher,
participants were limited to those for whom English is their primary language. Other
exclusion criteria included the presence of comorbidities (DM, neurological condition,
cognitive impairment, and prior pelvic organ surgeries), sexual dysfunction, and urinary
incontinence pre-operatively.
The contact information of every patient who were scheduled to undergo RARP was
provided to the secretary of the physical therapy office and the patient was contacted to
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set-up an appointment, at which time they were also informed that they may be eligible to
partake in a research study. Each participant had the choice of being tested at the
Jefferson Surgical Clinic or at Back to Basics Family Physical Therapy clinic in
Roanoke, VA. Potential participants were screened by the physical therapist for
exclusion criteria before participating in the study. If at any time during the screening
process it became apparent to the researcher that a participant did not meet the selected
criteria, the session was abbreviated and that participant s data was not included in data
analysis.
All eligible patients provided a signed informed consent prior to the initiation of any data
collection and randomi ation. At the time of enrollment, the study s purpose, protocol,
potential risks and benefits were explained in detail. Participants were informed that their
participation in the study was voluntary, and that they could withdraw at any time. Each
participant was provided with a copy of the informed consent form (informed consent
Appendix C).
The randomization schedule was generated by computer using simple random
assignment. The surgeon was blinded to intervention assignment. From the participants
who met the inclusion criteria and who agreed to participate by signing the informed
consent the same pre-operative demographics as described for the retrospective study
were collected as well as the PF strength (power 1-5/5) and endurance (# of repetitions
and 1-10 seconds hold) measures (data collection form prospective pre-op Appendix F) .
Instrumentation
PF strength and endurance was quantified using the modified Oxford and PERFECT
scales. PF strength was graded on a scale from 0/5 to 5/5 via the rectum with digital
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palpation. Digital palpation to measure PF strength has shown high intra-observer rates
of reproducibility, but low inter-examiner rates with a Cohen s kappa value of only
0.37.112 PF endurance was measured by sEMG via a self-adherent electrode (Easytrode
Pregelled Electrodes) placed on the skin nearest the rectum with a dual-channel sEMG
device (Pathway Synergy-3D, MR-20, Prometheus Group, Dover, NH). The Pathway
Synergy-3D is a continence evaluation and training system whereby PF function is
measured using a pressure sensor. The device is calibrated in accordance with
manufacturer directions to assure measurement accuracy. Endurance is calculated as the
number of repetitions and seconds of a maximum voluntary contraction of the PF
muscles before a reduction in peak force occurs on the recording. The use of sEMG for
the measurement of PFM activity has demonstrated good test-retest reliability (r = .86, p<
.001) and clinical predictive validity (p< 0.05).116,117
Procedures
Through random assignment, the 20 participants were separated into 2 groups of 10: one
received the pre-operative PFMT session while the other did not receive the pre-operative
PFMT education. An intention to treat at the completion of the study was offered if
incontinence persisted. Data was collected 2 weeks pre-operatively, and 6 weeks and 3
months post-operatively (Figure 3.2 flow diagram). The post-operative outcome
measures included the aforementioned intra-, and post-operative variables as in the
retrospective study, as well as PF strength and endurance, and functional assessment
questionnaires (data collection form prospective post-op Appendix D).
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Figure 3.2: Prospective study flow diagram

Testing:
The physical examination including the assessment of the PF muscle strength and
endurance was conducted by the primary investigator. PF strength was assessed through
rectal digital palpation. The patient was in the side lying position for ease of access and
visualization of the perineum. The therapist inserted her index finger in the anal canal to
the levator ani muscles and the patient was asked to contract the PF muscles by squeezing
around the finger. The patient was asked to pull the finger up and in, as if to stop the
urine flow . He was asked to squeeze the PF muscles as hard as possible for two seconds
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while the therapist graded the PF strength. A grade between 0 and 5 was given where 0 =
no discernible PFM contraction; 1 = flicker, or pulsing under the examining finger, a very
weak contraction; 2 = a weak contraction, an increase in tension in the muscle without
any discernible lift or squeeze; 3 = a moderate contraction characterized by a degree of
lifting of the posterior pelvic wall and squeezing on the base of the finger with indrawing of the perineum; 4 = a good PFM contraction producing elevation of the
posterior pelvic wall against resistance and in-drawing of the perineum; 5 = a strong
contraction of the PFM; strong resistance can be given against elevation of the posterior
pelvic wall. Observation of a cranial movement of the perineum and scrotum as well as
the digital palpation were also used to assure the patient s ability to correctly perform a
PFM contraction without the use of accessory muscles. Next, the PFM endurance was
measured with the aid of the sEMG biofeedback. After the skin was prepped with an
alcohol pad, the self-adherent electrode was placed on the perineal region between the
anus and the scrotum. For the first measure of endurance, the patient was asked to
contract the PF muscles as hard as possible and to sustain the contraction for up to 10
seconds. The time when the peak is no longer sustained was recorded. After a 60
seconds rest period, the second measure of endurance was taken. The patient was asked
to repeat as many strong contractions as possible by contracting the PF muscles for 2
seconds and resting for 4 seconds up to 10 contractions. The number of the repetition
when the maximum peak is no longer reached is recorded. Thereby, PF strength and
endurance was quantified using the modified Oxford and PERFECT scales with one
grade (0-5) for strength, and two grades for endurance (1-10 seconds sustained
contraction, and 1-10 repetitions).
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Intervention:
The intervention group received an approximately 30 minutes training session from the
investigator 2 weeks prior to surgery. Details were provided about the anatomy and
physiology of the lower urinary tract and the PF muscles (hand-out Appendix E).
Biofeedback sEMG was used for the PF exercise education portion. Participants
performed one set of quick contractions of 2 seconds hold with 4 seconds rest and one set
of sustained contractions for 10 seconds with 10 seconds rest for 10 repetitions each.
They received oral and written instructions on PFM contraction and a structured exercise
program (hand-outs Appendix F). Participants were asked to perform each set of the
quick twitches and the slow twitches four times a day or for a total of 80 squeezes per day
to be performed at home while lying, sitting, and/or standing. They were also instructed
on behavioral training and the use of a pelvic brace technique which involves the
repeated use of a voluntary PF muscle contraction in response to specific situations while
carrying out common activities of daily living, such as lifting objects, squatting, or
coughing (HEP log Appendix G). Participants started intervention from the day of the
training session until the day of surgery and resumed immediately following catheter
removal post-operatively until continence was returned.
The non-intervention group did not receive formal education of PFMT. These patients
were only given oral instructions from the urologist and from the investigator on PFM
anatomy and physiology without recommending a specific exercise regimen.
Outcome Measures
All patients were assessed by the physical therapist at the pre-operative session 2 weeks
prior to surgery and at the 6 weeks and 3 months follow-up sessions. All patients
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completed the self-administered condition-specific questionnaires IIQ-7 (Appendix H)
and UCLA-PCI (Appendix I).
The primary outcome measures are degree of incontinence as defined by number of pad
use per day (where 0 = return of continence, 1-2 = mild incontinence, 3-4 = moderate
incontinence, and >5 = severe incontinence), IIQ-7, and UCLA-PCI scores (where 0 on
the IIQ-7 and 100 on the UCLA-PCI indicate return of continence). The secondary
outcome measures are that of PF strength (where a grade of 0-1=poor, 2-3=fair, 4-5=
good strength) and endurance (where number of repetitions and seconds held 1-3=poor,
4-6=fair, 7-10= good endurance).
Data Analysis
Descriptive analyses including measures of central tendency and variability were used to
describe all variables. The t-test for continuous data and Chi-square test for nominal data
was used for comparisons between the two groups for the demographics as in the
retrospective study (see Table 3.1) with the addition of the functional questionnaires and
measures of PF function post-operatively (see Table 3.2). Each factor was evaluated
using the Chi-square (categorical variables), t-test (normally distributed continuous
variables), or Mann-Whitney (non-normally distributed continuous variables) test to
assess its association with less incontinence post-operatively. The variables were further
analyzed as a function of time post-op and PFMT condition in a 3X2 mixed-model
Analysis of Variance (ANOVA). For the variables without a pre-op value, a 2X2 mixedmodel ANOVA was used.
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The statistical analyses was conducted using the Statistical Package of Social Sciences
software (IBM SPSS, version 18.0, Armonk, NY). The significance level was set at the
0.05 level using a two-tailed test for all hypotheses.
Table 3.2 Variables and type post-op
PF muscle strength(0-5/5)
PF muscle endurance(1-10
secs and 1-10 reps)
Post-op UI(Y/N)
Severity (#of pads/day)

IIQ-7 (0-100)

UCLA-PI (0-100)

Time intervals

categorical (3 levels) Poor=0-1, Fair=2-3, Good= 4-5
continuous, but will be interpreted on a categorical
scale (3levels) Poor=1-3, Fair=4-6, Good=7- 10
categorical (2 levels)
continuous, but will be interpreted on a categorical
scale (4 levels)
where 0= no UI, 1-2=mild UI, 3-4=moderate UI,
5=severe UI
continuous, but will be interpreted on a categorical
scale (4 levels)
0=full continence, 1-33=mild UI, 34-66=moderate UI,
67=severe UI
continuous, but will be interpreted on a categorical
scale (4 levels)
100=full continence,99-67=mild UI, 66-34=moderate,
33=severe UI
6 weeks
3 months
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CHAPTER 4: RESULTS

INTRODUCTION
The primary aim of this investigation was to identify the possible benefits of a one-time
pre-operative PFMT session on patients undergoing a RARP. This study also attempted
to explore whether; the PFMT aids in limiting the severity and duration of post-op
urinary incontinence, and promoting the QoL. In addition, this research examined
whether the pre-operative PF strength can predict urinary incontinence after surgery.
This chapter presents the results of the data analysis and the results corresponding to the
specific research questions. The research consisted of a retrospective and a prospective
cohort study and thus this chapter is divided into two sections accordingly. The baseline
demographics and clinical variables are presented and the comparability of baseline
characteristics between the men who received the PFMT and those who did not is
examined. The second section addresses the specific research questions for each study.
The research questions for this study were as follows:
1. Do men who receive a one-time pre-op PFMT have less incontinence
following the robotic assisted daVinci prostatectomy than men who do not?
2. What are the differences in PF muscle strength and demographic variables
between patients with more vs. fewer incidence of urinary incontinence?
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3. Do men who present with the predictive factors identified in the retrospective
study have less symptoms of incontinence following the robotic assisted
daVinci prostatectomy vs. those who do not?
4. Do men who have received the one-time pre-op PFMT session present with
improved PF strength, less incontinence, and better quality of life scores in the
early stages following the robotic assisted daVinci prostatectomy compared to
those who did not?
For the retrospective study, the Chi-square test was used to compare whether or not
incontinence is present and the t-test was used to compare the severity of incontinence
between the two groups. Logistic regression analysis was used to assess the factors that
are predictors of less incontinence post-operatively. For the cohort study, logistic
regression analysis was used to assess whether men who presented with the predictive
factors have incontinence compared to those who do not. The Mann Whitney U was used
to compare the two groups in regards to severity of incontinence, quality of life, and PF
strength and Friedman s ANOVA or Wilcoxon Signed Rank was used to examine
changes over time
RETROSPECTIVE STUDY
Participants
A total of 393 charts of men between the ages of 51 and 76 years old who had undergone
RARP between 1/1/2008 and 12/31/16 were reviewed for possible study eligibility.
Records were excluded if there was not sufficient information available, or if there were
any intra-op or post-op complications. Data collection was performed until the minimal
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number of subjects (70 in each group) was reached. One hundred and forty men with a
mean age of 62.79 (standard deviation, 7.07) years (range, 51-76 years) satisfied the
eligibility criteria with 70 men for inclusion in the PFMT group and 70 men in the control
group. Descriptive characteristics for the groups are presented in Table 4.1. The mean
(or median), standard deviation (or interquartile range), 95% confidence intervals for the
mean (95% CI) and range are provided for age (K-S = .090, p = .008), weight, height (KS = .092, p = .005) , BMI, ethnicity, clinical T-stage, Gleason score, PSA, NVB
preservation and year of surgery. Comparison revealed no significant differences
between the 2 groups for any of the variables.

Table 4.1 Characteristics of participants: retrospective study
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Question 1: Do men who receive a one-time pre-op PFMT have less incontinence
following the robotic assisted daVinci prostatectomy than men who do not?
Chi Square was used to compare the presence of incontinence between the two groups at
the 6 weeks, 3 months and 12 months post-op times (Table 4.2, Figure 4.1). The effect
was significant for all three time periods; 6 weeks, Fisher s Exact p = .001,
0.286; 3 months,
< .0001,

2

(1) = 42.73, p < .001,

(phi) = -0.567; 12months,

2

(1) = 20.47, p

(phi) = -0.398. The negative sign of the Phi coefficient indicates that presence

of PFMT is associated with absence of incontinence.

Table 4.2.a Comparison of presence of incontinence at 6 weeks
Incontinence
No
Yes
1
69
13
57
14
126

Incontinence at 6 weeks
PFMT

No
Yes

Total

Total
70
70
140

Table 4.2.b Comparison of presence of incontinence at 3 months
Incontinence
No
Yes
9
61
48
22
57
83

Incontinence at 3 months
PFMT

(phi) = -

No
Yes

Total

Table 4.2.c Comparison of presence of incontinence at 12 months
48

Total
70
70
140

Incontinence
No
Yes
38
32
63
7
101
39

Incontinence at 12 months
PFMT

No
Yes

Total

Total
70
70
140

Figure 4.1 Comparison in continence over time
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The Mann-Whitney U test was used to compare the severity of incontinence through the
number of pads used per day between the two groups. At 6 weeks, the PFMT group
(median = 3.00) used significantly fewer pads per day than the non-PFMT group (median
= 1.00), U = -7.65, p < .001 (see Figure 4.1). At 3 months, the PFMT group (median = 0)
also used significantly fewer pads per day than the non-PFMT group median = 2.00), U =
-7.72, p < .001 (see Figure 4.2). Even though both medians were zero, there also was a
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significant difference in pad use at 12 months, U = -4.94, p < .001; the difference resulted
from 7 PFMT patients using only 1 pad per day while the other 63 reported zero pads
with only 38 non-PFMT patients reported zero pads while the other 32 reported a range
from 1 to 6 pads.
Figure 4.2 Comparison number of pads per day at the 3 time points

Median Number of Pads per Day: All
Participants
3.5
3
2.5
2

Control

1.5

PFMT

1
0.5
0
6 Weeks

3 Months

12 Months

Question 2: What are the differences in PF muscle strength and demographic variables
between patients with more vs. fewer incidence of urinary incontinence?
Each factor was evaluated using the Chi Square (categorical variables), t-test (normally
distributed continuous variables), or Mann-Whitney U (continuous non- normally
distributed variables). Data analysis results are presented in Table 4.3
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Age: There was no significant difference between patients with and without incidence of
urinary incontinence at 6 weeks (U = -1.353, p = .176), 3 months (U = -0.357, p = .721),
and at 12 months (U = 1.339, p = .181. Age is not related to incidence of incontinence.
Race: Comparisons were done between the white and non-white because there are too
few nonwhites to analyze them in separate categories. There was no significant difference
between patients with and without incidence of urinary incontinence at 6 weeks (Fisher s
Exact p = .363). Fisher s Exact test was used because at least one cell had an expected
value less than five (5), which violates an assumption for Pearson (traditional) Chi
Square. At 3 months there was a significant difference between patients with and without
incidence of urinary incontinence (

2

(1) = 5.218, p = .022). Nonwhites (86.7%) were

more likely to be incontinent at 3 months than Whites (59.3%). There was no significant
difference between patients with and without incidence of urinary incontinence at 12
months (

2

LR

(1) = 0.012, p = .913). Race was related to incontinence, but only at 3

months.
Weight: There was no significant difference between patients with and without incidence
of urinary incontinence at 6 weeks (t (138) = 0.464, p = .644), 3 months (t (138) = 0.879,
p = .381), and at 12 months (t (138) = -0.220, p = .826). Weight was not related to
incidence of incontinence.
Height: There was no significant difference between patients with and without incidence
of urinary incontinence at 6 weeks (U = -0.108, p = .914), 3 months (U = 1.391., p =
.164), and at 12 months (U = 1.487, p = .137). Height was not related to incidence of
incontinence.

51

BMI: There was no significant difference between patients with and without incidence of
urinary incontinence at 6 weeks (U = 0.27, p = .784), 3 months (U = -0.38, p = .703), and
at 12 months (U = -0.77p = .444). BMI was not related to incidence of incontinence.
PSA: There was no significant difference between patients with and without incidence of
urinary incontinence at 6 weeks (U = -0.003, p = .997), 3 months (U = -0.405, p =. 685),
and at 12 months (U = 0.049, p = .961). PSA was not related to incidence of
incontinence.
Gleason: There was no significant difference between patients with and without
incidence of urinary incontinence at 6 weeks (U = 0.354, p = .723), 3 months (U = 0.409, p = .683), and at 12 months (U = -0.497, p .619). Gleason score and incidence of
incontinence are not related.
Clinical Stage: Clinical stage is being treated as a categorical variable. There was no
significant difference between patients with and without incidence of urinary
incontinence at 6 weeks (

2

.296), and at 12 months (

2

2

LR

(2) = 0.328, p = .849), 3 months (

LR

(2) = 0.893, p = .640). Clinical stage and incidence of

LR

(2) = 2.434, p =

incontinence are not related.
Symptoms pre-op: There was no significant difference between patients with and without
incidence of urinary incontinence at 6 weeks (
(1) = 2.887, p = .089), and at 12 months (

2

LR

2

LR

(1) = 0.155, p = .694), 3 months (

2

(1) = 1.590, p = .207). Symptoms pre-op

and incidence of incontinence are not related.
PFM Strength: This analysis includes only the 70 patients who received PFM Therapy.
There was no significant difference between patients with and without incidence of
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LR

2

urinary incontinence at 6 weeks (
p = .303), and at 12 months (

2

ML

(2) = 0.098, p = .952), 3 months (

2

ML (2)

= 2.390,

(2) = 0.430, p = .806). PFM Strength and incidence of

ML

incontinence are not related.
PFM Endurance: This analysis includes only the 70 patients who received PFM Therapy.
There was no significant difference between patients with and without incidence of
2

urinary incontinence at 6 weeks (

ML

0.833, p = .659), and at 12 months (

2

(2) = 1.950, p = .377), 3 months (
ML

2

ML

(2) =

(2) = 0.841, p = .657). PFM Endurance and

incidence of incontinence are not related.
NVB Status: Because there were only 18 unilateral patients and only 5 no-preservation
patients, NVB status was recoded as a dichotomous variable: Bilateral versus Other.
There was no significant difference between patients with and without incidence of
urinary incontinence at 6 weeks (Fisher s Exact p = .466), 3 months (
.118), and at 12 months (

2

2

(1) = 2.44, p =

(1) = 0.091, p = .763). NVB Status and incidence of

incontinence are not related.
PT post-operative: Post-operative physical therapy has a significant but relatively weak
relationship with incontinence at 6 weeks,

2

LR

(1) = 7.995, p = .005,

= .185. Of the

incontinent patients, 26.2% received post-op PT, while 0% of the continent patients
received PT. At 3 months there was a moderate association between post-operative
physical therapy and incontinence,

2

LR

(1) = 32.162, p < .001,

= .426. Among the

incontinent patients 38.6% received PT, while 1.8% of the continent patients received PT
at 3 months. The association between post-operative physical therapy and incontinence
remain moderate at 12 months,

2

LR

(1) = 40.240, p < .001,
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= .556. Among those who

were incontinent, 61.5% received PT, while only 8.9% of the continent patients received
PT at 12 months. Post-operative physical therapy and incidence of incontinence are
related at all three time periods.
Intervention (additional surgery post-op): At 6 weeks, there was an association between
intervention and incidence of urinary incontinence (

2

LR

(1) = 5.578, p = .018,

= .152),

however weak. Among incontinent patients, 19.0% received further intervention, while
0% of continent patients received an intervention at 6 weeks. At 3 months, there was a
stronger relationship between intervention and incidence of urinary incontinence (
(1) = 28.449, p < .001,

2

LR

= .377). Among those who were incontinent 71.1% received

further intervention, while 0.0% of the continent patients received intervention. At 12
months, there was also a strong relationship between intervention and incidence of
urinary incontinence (

2

LR

(1) = 64.258, p < .001,

= .690). Among incontinent patients,

59.0% received Intervention, while only 1.0% of continent patients received an
intervention. Intervention post-op and incidence of incontinence are strongly related and
the relationship gets stronger the longer the patient is post-operative.
Of all of the demographic and pre-surgical variables, only race is related to incontinence,
and that is only at 3 months. To see if race affects the relationship between PFMT and
incontinence, a logistic regression was run on incontinence in which PFMT and race were
entered as predictors. For each analysis, race was entered into the prediction first, which
statistically controlled for any relationship race might have with incontinence when
testing the relationship for PFMT. At 6 weeks, PFMT was a significant predictor (p =
.009), but race was not (p = .998). At 3 months, race was a significant predictor (p =
.016) as expected, but its presence in the prediction equation did not eliminate the PFMT
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as a predictor (p < .001). At 12 months, race was not a significant predictor (p = .913)
while PFMT was (p < .001).

Table 4.3.a Incontinence factors: retrospective study at 6 weeks

Variable

Incontinence

Age
(years)
Race
(% white)
Weight
(lbs)
Height
(feet)

No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes

BMI

PSA
Gleason (%
Score = 6)
Clinical
Stage (%
Stage = I)
Symptoms
(% none)
PFM
Strength
(% Good)
PFM
Endurance
(% Good)
NVB Status
(%
preserved)

%

Mean

Median
66.0
63.5

SD
or
IQR
7.5
7.3

95%
Confidence
Interval

Range
45-73
44-76

100.0
88.1

p
.176
.067

195.2
198.9
5.8
5.9
27.7
28.3
5.92
5.60
64.3
53.2
50.0
43.7

23.1
29.1
0.25
0.33
3.24
3.84
2.33
3.24

181.9-208.6
193.8-204.1
25.9-29.6
27.6-29.0

155-228
150-306
5.6-6.2
5.1-6.4
21.6-33.5
20.5-40.1
3.28-8.30
1.55-28.14

.644
.914
.575
.997
.165
.849

No
Yes
No
Yes

78.6
73.8
30.8
33.3

No
Yes

7.7
14.0

.377

No
Yes

92.9
82.5

.279

.694
.952
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PT post-op
(% Yes)
Intervention
post-op
(% Yes)

No
Yes
No
Yes

0.0
26.2
0.0
19.0

.005
.018

Table 4.3.b Incontinence factors: retrospective study at 3 months

Variable

Incontinence

Age
(years)
Race
(% white)
Weight
(lbs)
Height
(feet)

No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes

BMI
PSA

Gleason (%
Score=6)
Clinical
Stage (%
Stage=I)
Symptoms
(% none)
PFM
Strength
(% Good)
PFM
Endurance
(% Good)
NVB Status
(%
preserved)

%

Mean

Median
64.0
62.0

SD
or
IQR
10.0
8.0

95%
Confidence
Interval

Range
44-76
44-76

96.5
84.3

p
.721
.015

196.0
200.3
5.8
5.9
28.2
28.3
5.92
5.60
54.4
54.2
50.9
39.8

24.4
30.9
0.33
0.42
3.19
4.15
3.12
2.90

189.5-202.5
193.6-207.1
27.3-29.0
27.4-29.2

150-250
150-306
5.4-6.2
5.1-6.4
21.6-37.0
20.5-40.1
1.72-28.14
1.55-15.10

.381
.164
.796
.685
.363
.396

No
Yes
No
Yes

66.7
79.5
29.2
40.9

No
Yes

14.6
9.1

.659

No
Yes

89.5
79.5

.110

.089
.303
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PT post-op
(% Yes)
Intervention
post-op
(% Yes)

No
Yes
No
Yes

1.8
38.6
0.0
28.9

.001
.001

Table 4.3.c Incontinence factors: retrospective study at 12 months

Variable

Incontinence

Age
(years)
Race
(% white)
Weight
(lbs)
Height
(feet)

No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes

BMI
PSA

Gleason (%
Score = 6)
Clinical
Stage (%
Stage = I)
Symptoms
(% none)
PFM
Strength
(% Good)
PFM
Endurance
(% Good)
NVB Status
(%
preserved)

%

Mean

Median
64.0
65.0

SD
or
IQR
8.5
7.0

95%
Confidence
Interval

Range
44-76
49-76

89.1
89.7

p
.181
.913

198.9
197.7
5.8
5.9
28.4
27.9
5.75
5.90
53.5
56.4
46.5
38.5

29.9
24.6
0.33
0.42
3.88
3.54
2.95
3.90

192.9-204.8
189.7-205.7
27.7-29.2
26.7-29.0

150-306
150-240
5.4-6.4
5.1-6.4
21.6-38.7
20.5-40.1
1.55-28.14
3.60-15.10

.826
.137
.452
.961
.649
.640

No
Yes
No
Yes

77.2
66.7
31.7
42.9

No
Yes

12.7
14.3

.657

No
Yes

84.2
82.1

.765

.207
.806
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PT post-op
(% Yes)
Intervention
(% Yes)

No
Yes
No
Yes

8.9
61.5
1.0
59.0

.001
.001

PROSPECTIVE STUDY
Participants
A total of 49 men between the ages of 53 and 72 years old who underwent RARP
between November 2017 and November 2018 were screened for possible study
eligibility. Men were excluded if their surgery was scheduled less than 2 weeks from the
interview, if there was a language barrier, presence of co-morbidities (DM, neurological
conditions, cognitive impairment, or prior pelvic surgeries), sexual dysfunction, or
urinary leaking pre-op, or if there were post-op complications. Screening was performed
until 20 men who met the inclusion criteria accepted to participate in the study. Of the 29
men who did not participate, 6 declined, 14 had co-morbidities, 1 had urinary leaking
pre-op, 7 had their surgery scheduled within a week of the screening date, and 1 had postop complications. The 20 participants chose to be seen at the physical therapy clinic.
They signed the informed consent form and 10 each were randomized in either the PFMT
group or the control group through computer generated simple randomization. Men who
were assigned an odd number were placed in the control group, while those who received
an even number were placed in the intervention group. Data collection was performed 2
weeks prior to surgery and at the 6 weeks and 3 months post-op times. Demographic and
clinical data for the groups are summarized and presented in Table 4.4. The mean (or
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median), standard deviation (or interquartile range), 95% confidence intervals for the
mean (95% CI) and range are provided for age, weight, height, BMI, ethnicity, clinical Tstage, Gleason score, PSA, NVB preservation, PFM strength and endurance, and level of
education. All continuous variables were tested for normality using the KolmogorovSmirnov test. Because of small sample sizes all group comparisons were accomplished
with Mann-Whitney U or Chi Square. Changes over time (repeated measures) were
assessed via Friedman s ANOVA or Wilcoxon Signed Rank. There are no differences
between the groups.
Table 4.4 Characteristics of participants: prospective study
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Question 3: Do men who present with the predictive factors identified in the
retrospective study have less symptoms of incontinence following the robotic assisted
daVinci prostatectomy vs. those who do not?
As is noted in Table 4.4, there was no demographic differences between the PFMT and
control groups. Race was the only demographic variable related to incontinence in the
retrospective study and, in this study small numbers required it be reduced to categories
of white and non-white.
Chi Square with Fisher s Exact test was used to assess the correlation between race and
incontinence. Correlation was not found at 6 weeks (p = .495; with 10 whites and 2 nonwhites incontinent, 8 whites and 0 non-whites continent), or at 3 months (p = .479; with 9
whites and 2 non-whites incontinent, 9 whites and 0 non-whites continent).
Question 4: Do men who have received the one-time pre-op PFMT session present with
improved PF strength, less incontinence, and better quality of life scores in the early
stages following the robotic assisted daVinci prostatectomy compared to those who did
not?
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Variables were analyzed as a function of time and PFMT condition in a 3 (Time: pre-op,
6 weeks, 3 months) X 2 (Condition: PFMT vs. Control) mixed-model Analysis of
Variance; Time is a repeated-measures variable and Condition is a between-subjects
variable. For variables without a pre-op value, a 2 (Time) X 2 (Condition) mixed-model
ANOVA was used.
PFM Strength: There is a significant main effect for time, F(2,36) = 4.415, p = .038,
partial

2

= .197. PFM Strength increased over time. Neither the main effect for

Condition, F(1, 18) = 0.917, p = .351, partial
interaction, F(2, 36) = 1.358, p = .266, partial

2

= .048, nor the Time X Condition

2

= .070, were significant. The PFM

strength seemed to increase more in the PFMT group comparing to the control condition
(Figure 4.3) but the difference was not statistically significant.

Figure 4.3 PFM Strength as a Function of Condition and Time
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PFM Endurance: The results for PFM Endurance display a pattern similar to that for PFM
Strength. There is a significant main effect for Time, F(2,36) = 20.027, p < .001, partial
2

= .527. PFM Endurance increased over time, and the effect size is quite large. Neither

the main effect for Condition, F(1, 18) = 0.100, p = .755, partial
X Condition interaction, F(2, 36) = 2.514, p = .095, partial

2

2

= .006, nor the Time

= .123, were significant.

The PFM endurance seemed to increase more in the PFMT group comparing to the
control condition (Figure 4.4) but the difference was not statistically significant.

Figure 4.4 PFM Endurance as a Function of Condition and Time

Urinary Incontinence: Changes in the rate of urinary incontinence between conditions
were assessed via Fisher s Exact Chi Square separately for occurrences at 6 weeks and at
3 months. As is evident in Table 4.8 below, incontinence was significantly more likely in
the Control condition than in the PFMT condition at both 6 weeks and 3 months after the
surgery.

62

Table 4.5 Urinary Incontinence as a Function of Condition and Time
Condition
Time Post-op
6 Weeks

3 Months

Incontinence

Control

PFMT

N

0

8

Y

10

2

N

1

8

Y

9

2

p < .001

p < .006

Pads per Day: Wilcoxon Signed Rank nonparametric test was used to compare number of
pads at 6 weeks versus 3 months; there is a significant difference, W = -2.81, p = .005, 6Week Median = 1, Interquartile range = 3; 3-Month Median = 0, Interquartile range = 2.
Fewer pads per day were used at 3 months than at 6 weeks. Mann-Whitney U test was
intended to be used to test for differences between conditions (PFMT versus Control).
For 6 weeks, it was not possible to conduct an analysis because there was too little
variability in the PFMT group. As is evident in Figure 4.8 below, only two participants
(#1 and #12) in the PFMT group reported using any pads at 6 weeks.
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Figure 4.5 Pads per Day as a Function of Condition at 6 Weeks

The same issue with variability occurred at 3 months post-operative. Only one participant
(#12) in the PFMT conditions was still using a pad at 3 months (Figure 4.6). There was a
distribution of pads used in the control condition, with a median value of 1.5 pads per
day. Thus, despite the lack of a statistical test, it is obvious that fewer pads per day were
used in the PFMT condition than in the control condition.
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Figure 4.6 Pads per Day as a Function of Condition at 3 Months

IIQ7: IIQ7 scores at 6 Weeks and at 3 Months are normally distributed, so a 2 (Time) X 2
(Condition) ANOVA was used to examine mean differences. Both main effects were
significant, but not the interaction. IIQ7 for the PFMT group (M = 20.45, SE = 5.74) was
significantly lower, F (1,18) = 8.77, p = .008, partial

2

= .328, than the mean for the

control group (M = 45.50, SE = 5.74). Also, IIQ7 at 6 weeks (M = 40.70, SE = 4.74) was
significantly higher, F (1, 18) = 15.98, p = .001, partial

2

= .470, than the mean IIQ7 at 3

months (M = 24.25, SE = 4.36). As is evident in Figure 4.7, the advantage for the PFMT
was consistent at both times; the interaction was not significant, F(1, 18) = 0.83, p = .374,
partial

2

= .044. It is worth noting that the mean score for the control group at 3 months

is still higher than the mean score for the PFMT group at 6 weeks.
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Figure 4.7 IIQ-7 Scores as a Function of Condition and Time

UCLA-PCI Function: Scores on the UCLA Function measure are normally distributed, so
a 2 (Time) X 2 (Condition) ANOVA was used to examine mean differences. Both main
effects were significant, but the interaction was not, F (1,18) = 0.54, p = .470, partial

2

=

.029. Those who received PFMT (M = 69.42, SE = 5.60) scored significantly higher, F
(1,18) = 21.82, p < .001, partial

2

= .548, than those in the control group (M = 32.46, SE

= 5.60). Function score was higher at 3 months (M = 56.61, SE = 4.32) than at 6 weeks
(M = 42.28, SE = 4.33), F (1,18) = 12.01, p = .003, partial
displayed in Figure 4.8.
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2

= .400. The pattern is

Figure 4.8 UCLA-PCI Function Scores as a Function of Condition and Time

UCLA-PCI Bother: The UCLA-PCI Bother scores were not normally distributed, K-S6
weeks

= .258, p = .001, K-S3 months = .216, p = .016, so Mann-Whitney U tests were

performed to test for differences over time as well as differences between groups. In
Figure 4.9 it is apparent that the PFMT group scored significantly higher at 6 weeks (U =
3.10, p = .002), and at 3 months (U = 2.84, p = .005), than the control group. Both groups
improved over time, however the change did not yield statistical significance, PFMT W =
1.26, p = .206, and Control W = 1.32, p = .187.
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Figure 4.9 UCLA-PCI Bother Scores as a Function of Condition and Time
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CHAPTER 5: DISCUSSION

INTRODUCTION
The primary purpose of this research was to explore the benefit of receiving a one-time
pre-operative PFMT in men following a da Vinci robotic-assisted radical prostatectomy
(RARP). Despite advancing technology and the use of techniques geared to preserve or
reconstruct the surrounding peritoneal fascia, bladder neck, and neurovascular bundle
(NVB) the most common side effects remain impotence and urinary incontinence. As
many as 87% of men may experience incontinence immediately following
prostatectomy1,2,18 thus impacting one s quality of life.
Four specific questions were developed in order to test the relationship between a onetime pre-op PMFT session and urinary incontinence post-op. The first two questions,
which were explored through a retrospective study, were on whether the individuals who
received the pre-op PFMT had less incontinence than those who did not, as well as
identifying factors that are associated with less incidence of urinary incontinence postoperatively. The last two questions, through a prospective cohort study, were on whether
the men who presented with the predictive factors identified in the retrospective study
had less incontinence than those who did not, and whether men who have received the
one-time pre-op PFMT session present with improved PF strength, less incontinence, and
better quality of life scores following the robotic assisted daVinci prostatectomy
compared to those who did not.
This chapter discusses the findings and compares the results to previous work in the
literature, and the contribution of this study to the clinical management of men who will
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be undergoing RARP. The limitations and recommendations for future research and a
summary of conclusions were also provided.
INCIDENCE OF UI POST-OP
Research questions 1 and 4 addressed whether men who received the pre-op PFMT have
less incontinence following the RARP than the men who did not. There was a significant
difference between the 2 groups at the 3 points in time such that the men who received
the pre-op PFMT were more likely to be continent and also to a lesser degree even if they
were still incontinent than the men who did not receive the pre-op PFMT, with the
strongest effect at 6 weeks in both the retrospective and prospective studies.
The results agree with previous studies43,55,56,110,111 where it was also found that decreased
time to continence and severity of incontinence was present when a PMFT program was
offered pre-operatively. However, these studies provided one or more pre-op PFMT
sessions, as well as post-op PFMT. The current study provided only one pre-op session
and no post-op PFMT with the noted improvements. Therefore it results in potential cost
saving for the patients and the healthcare system by reducing the total number of visits
required. It was not the intent of this study to provide evidence on the ultimate number of
visits in order to maximize the effect. The ideal number of visits that can maximize the
benefits of PFMT still warrant further investigation.
The result is consistent with studies in which the advantage provided by a PMFT program
decreases over time. The results of this study generally show a stronger effect at 6 weeks
post-op. Parekh et al43 also found a PFMT advantage for early return of continence at 6
weeks and up to 3 months, but that advantage was no longer significant at 12 months.
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Centemero et al110 investigated the effect of a PFMT initiated 30 days prior to
prostatectomy. They found that pre-operative PFMT improved early with the rates of
continence of 59.3% at 3 months in the treatment group comparing to only 37.3% in the
control group. In the current study, the rate of continence at the same 3 months post-op
timeframe were a little higher in the PFMT group (68.6%) but lower in the control group
(12.9%). Two other studies54,55 have shown the most advantages of pre-op PFMT at the
early stages of 6 weeks post-op. Patel et al54 conducted a retrospective study on the
effect of 4 weeks of pre-op PFMT and also post-op PFMT and concluded the most
significant difference occurs at 6 weeks. A study by Sueppel et al, though with only 8
men, also demonstrates the strongest results at 6 weeks post-op with only one session of
pre-op PFMT.55
From the data collected for the retrospective study, the single PFMT session was
provided between 3 weeks to one day pre-op while the pre-op PFMT session was
generally provided 2 weeks pre-op for the prospective study. Studies have shown
benefits to pre-op PFMT sessions whether provided as several weekly sessions or as ours
as a single session and up to one month pre-op. Burgio et al111 provided a single
biofeedback PFMT session 2-4 weeks prior to surgery and in a similar study, Tienforti et
al56 provided the PFMT session only one day prior to surgery. Both studies also provided
post-op PFMT and found that their pre-operative PFMT hasten the recovery of urinary
control, with decreased incidence, duration, and severity of urinary incontinence lasting
until the 6 months follow-up.
Conversely, the study by Geraerts et al106 shows no benefit from pre-op PFMT compared
to post-op PFMT sessions. They found that both groups recovered continence to the
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same extent and that there was no difference in the time to continence when assessed at
the 1, 3, 6 and 12 month time points. In this retrospective investigation, among those
who received pre-op PFMT only 3 men required post-op PFMT and 2 required further
surgical interventions vs. 30 men in the control group required post-op PFMT and 23
required surgery. Only one in ten men in the control group of the prospective study
required post-op PT once the study was completed. With the similar results as having
several post-op sessions, one could argue that one pre-op session has more value, is more
cost effective and less bothersome to men undergoing RARP comparing to post-op
training.
While studies have found no benefit of biofeedback vs. verbal instructions58,104 or the use
of E-stim vs. PMFT alone105, our pre-op PFMT consisted of verbal instructions in
combination with biofeedback. This was chosen in order to assure that a correct PF
contraction was performed in isolation and also as a means to measure PF endurance.
The men who did not receive the pre-op PFMT session only received verbal instructions
from the surgeon or they found information on the internet without specific protocol and
guided instruction. One observational study55 compared the effects of the pre-operative
physiotherapist guided PFMT versus verbal instructions by the surgeon provided 4 or
more weeks prior to the surgical intervention. The study found that at 6 weeks the
physiotherapist guided PFMT participants were drier compared to those receiving
instructions by the surgeon, but the effect disappeared by 3 months. In this study,
additional written instructions regarding exercise regimen and behavioral strategies to
prevent leaking during functional activities were also provided by the therapist. This
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additional education/information may account for the improvements noted compared to
PF exercises alone when provided through written or verbal instructions.
In conclusion, the response to the question whether men who received the pre-op PFMT
have less incontinence following RARP than the men who did not is a resounding yes.
The key difference between this study and other studies is that this study showed the
benefit of one single session pre-op in reducing the severity of incontinence post-op at the
very early stages at 6 weeks post-op.
ASSOCIATED FACTORS
Research questions 2 and 3 addressed whether any factors, such as PF muscle strength
and demographic variables, are associated with less incidence of urinary incontinence.
The factors included age, race, height, weight, BMI, PSA, Gleason score, clinical Tstage, symptoms, PF strength, PF endurance, and NVB status.
In our study none of the pre-op demographics were shown to be related to incontinence
post-op including PF strength and endurance. Of all the demographics and pre- and perisurgical variables, only race was related to incontinence in the retrospective study and
that only at the 3 months mark. No other studies have looked at race as a predictor of UI
post prostatectomy. However, further analysis revealed that its presence did not affect the
relationship between PFMT and incontinence.
Two small scale studies7,72 found that lower BMI correlated with a faster return of
continence at 12 months post-op. However, other studies support our findings. The study
by Novara et al74 found that no variables related to prostate CA correlated with UI postop. A large study by Nilsson et al73 did not find that BMI had an effect on the prevalence
73

of UI at a 2 year follow-up. Lavigueur-Blouin et al22 also found that BMI and PSA were
not statistically significant predictors of very early continence.
All previous studies5,7,20-23,71,72,74,76 that have looked at age as a predictor of risk of UI
post-prostatectomy have found that younger age (<70 years old) correlates with faster
return of continence. Only 19 patients out of 140 men in the retrospective study were
over the age of 70 years old with a median of 62.5 years old for the control group and 65
years old for the PFMT group. Only 2 out of 20 men in the prospective study were over
the age of 70 years old with a median of 62 years old for both the control and the PFMT
groups. This renders our population in the younger age range and thus may be attributed
to the lack of relationship found.
Studies generally agree that a nerve sparing technique is superior to a non-sparing
technique and is associated with recovery of continence at one year post-op5,7,20 and as
early as 3 months post-op.9,21,75,77,78 The surgeons participating in this study commonly
use a nerve sparing technique in which 84% of men received the bilateral nerve sparing
and 13% the unilateral nerve sparing technique in the retrospective study. Five out of 20
men in the prospective study received the unilateral nerve sparing technique. The study
by Kaye et al7 reported similar recovery with either technique and thus this may also be
the reason for lack of relationship in our research as only 5 men underwent a non-sparing
procedure in the retrospective study.
A few studies76,77 have also reported on improved continence within 3 months post-op
with a lower T-stage and Gleason score. A higher stage or Gleason score of 7 or more
indicates a more aggressive CA. Ninety-four percent in the retrospective study and 100%
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in the prospective study of our population was categorized in the grades I or II T-stages
and at a median of 6 on the Gleason score. Most likely early diagnostic screening
accounts for the early detection of prostate CA before the CA has had a chance to grow
outside the prostate and become more aggressive. Surgical procedures therefore do not
need to be as invasive and do not cause as much damage to the surrounding tissues when
the CA is better contained and thus possibly accounts for the lack of correlation noted in
our research.
In conclusion, this study did not identify any factors, including PF strength and
demographic variables that were associated with incidence of urinary incontinence postop. In such, this study shows that regardless of pre-op variables, it was the PFMT session
pre-op that aided in reducing the severity of incontinence post-op.
PF STRENGTH/ENDURANCE
The relationship between PF strength/endurance and incontinence is further explored in
questions 3 and 4.
This study used rectal digital palpation and the Oxford scale to grade PF strength and did
not show that PF strength pre-op was a predictor of continence post-op. Even men with
good strength have some chance of developing urinary incontinence. However, the
prospective study shows that there is an inverse relationship between urinary
incontinence and PF strength/endurance in that men with good PF strength/endurance are
less likely to experience urinary incontinence and those with poor PF strength/endurance
are almost certain to have urinary incontinence at both 6 weeks and 3 months post-op.
This relationship between PF strength/endurance and urinary incontinence gets stronger
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over time. There are a few studies correlate PF muscle weakness to incidence of urinary
incontinence following radical prostatectomy, but only one other also notes the
relationship getting stronger over time. The pilot study by Rigatti et al51 used
perineometric measures pre-op and post-op to assess PF tone and found a significant
difference between pre-op pressures in continent vs. incontinent men post-op at 1 and at 3
months when all men received PFMT pre-op and post-op.
Song et al52 used MRI as a means to measure the thickness of the PF muscles and
established that continence was related with increased thickness at 3 and 6 months postop, but PFMT was not provided in their study. The study by Ocampo-Trujillo et al53
shows histologic PF muscle changes through an increase in cross-sectional area of the
muscle fibers of the external urethral sphincter which correlated with higher pressures of
PF contraction and improved continence. However, the pre-op PFMT consisted of a 30
days intense training prior to surgery. In this study the one pre-op session occurred less
than 3 weeks prior to surgery and thus morphological changes most likely did not occur
yet.
The study by Ribiero et al99 also used the Oxford scale to quantify PF strength but
examined the effects of early post-op PFMT. They found that improved PF strength
hasten the recovery of continence in the PFMT group up to 12 months post-op.
The prospective study we conducted shows that PF strength and endurance improve
significantly over time in both groups but more rapidly in the PFMT group, though not
statistically significant. Incontinence, however, is significantly more likely in the control
group at 6 weeks and 3 months, with noted fewer pads/day used in the PFMT group.
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The lack of significance in this prospective study in regards to improvements in PF
strength/endurance may be due to the small sample size, but also because of subjects in
our control group were doing some type of Kegel exercises either found on the internet or
as recommended by the surgeon. The improvements seen in the severity of incontinence
post-op in the PFMT group may therefore align with the rationale originally suggested by
B∅ et al84 that an intentional PF contraction clamps the urethra, thereby increasing the
urethral pressure, and that a stronger PF tone provided improved bladder neck support,
thereby limiting its downward movement during an increase in intra-abdominal pressure
which in turn prevents urine leakage. The men in the PFMT group were taught how to
perform a correct and isolated PF contraction with additional instructions in what is
commonly called a Knack maneuver. This consists of a pelvic bracing technique to be
used during such activities that may be causing an increase in intra-abdominal pressure
that may result in a leak, such as while coughing/sneezing, lifting or during changes of
position. The study by Rajkowska-Labon et al46 used sEMG to record PF muscle activity
and assess post-op improvements in continence through PFMT and found a statistically
significant difference in response time, indicating improved neuromuscular coordination.
This could further explain our findings of improved continence in the intervention group.
QUALITY OF LIFE
The effect of pre-op PFMT on the QoL scores was explored in research question 4. The
IIQ-7 and UCLA-PCI urinary domains were used to assess the impact of incontinence on
quality of life.
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This prospective study where men received only one pre-op PFMT session found the
functional impact of UI to be getting smaller over time in both groups, but with a
significant lesser impact on QoL in the PFMT group. Furthermore, the impact at 3
months in the control group was still higher than the impact to the PFMT group at 6
weeks. No other study has previously noted this finding. The measure of the impact of
UI on QoL relies on self-reporting measures. Possibly the men in this study were aware
that the measure of the severity of UI was the primary purpose of this investigation and
wanted to show good results. A two year follow-up study by Sacco et al18 showed that
QoL is not impacted in men using <1pad/day, but is impacted in men using > 2 pads/day.
In our study, men who received the PFMT session all used 0 or 1 pad/day by 6 weeks and
thus may attest for the significantly improved QoL scores at this point in time.
Studies further show that self-esteem and health locus of control influence QoL.138 A
recent large-sized prospective trial found that preparedness before surgery for urinary
problems decreases the impact of UI up to one year post-op.139 The pre-op PFMT and
education in behavioral strategies provided in this study possibly result in reassurance for
the patients and improve their confidence that urine can be controlled or stopped in
situations where leaking could occur. Therefore helping to overcome the physical,
psychosocial, and emotional problems derived from the loss of bladder control in the first
few months following surgery.
In conclusion, the functional impact of incontinence gets smaller over time in both
groups, but with a significant lesser impact on QoL in the PFMT group. The impact at 3
months in the control group was still higher than the impact to the PFMT group at 6
weeks.
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IMPLICATIONS AND RECOMMENDATIONS
PF Strength and Endurance
The primary finding of this investigation is the strong association between PFMT pre-op
and the reduced incidence of UI post-op at all points in time, with the strongest effect
being at 6 weeks post-op with only one pre-op PFMT session. Furthermore, PF
strength/endurance improved more rapidly in the PFMT group with the resulting impact
of UI on QoL less bothersome in the PFMT group. This effect was also strongest at the
6 weeks post-op point. Further larger studies are needed to corroborate the findings of
this study and to determine whether 1 session only pre-op is beneficial. However, this
preliminary research appears to support the benefits of a pre-op PFMT program. Based
on these findings, prophylactic PFMT could be recommended for patients undergoing
RARP and could be part of the guidelines for management of UI as a routine pre-op
preparation prior to RARP in urology practice.
Even though the study failed to identify PF strength and endurance as predictors of UI
post-op, the relationship between PF strength/endurance and UI post-op was shown to be
getting stronger over time. The one-time session of PFMT was provided anywhere
between 1 day to 3 weeks pre-op. Possibly initiating PFMT at least four weeks prior to
surgery would allow for muscle bulk/tone51,52 and improved strength50,99 to occur prior to
surgery, thereby improving urinary control sooner post-op. Recommendations in
behavioral strategies should be provided as well, including the use of a pelvic bracing
technique during functional activities that may cause UI post-op. This would allow for
the practice of this essential skill pre-op when the perineum is still intact. Patients would
be able to stop urine flow in situations of an increase in intra-abdominal pressures or with
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urgency. Giving patients reassurance and improved confidence that urine can be
controlled would help overcome the physical, psychosocial, and emotional problems
derived from loss of bladder control.
PFMT programs
In most clinical practice a post-op PFMT program would typically be initiated once the
severity of UI has been established on follow-up with the surgeon, generally 4-6 weeks
post-op. This study shows improvements of UI and less bother from UI by 6 weeks. Of
all the patients who received the pre-op PFMT none required post-op PFMT in the
prospective study and only 3 out of 70 men in the retrospective study. Most pre-op
PFMT programs including this one consist of 1 to 4 sessions. By contrast there is high
variability in terms of duration of programs (3 to 12 months) and number of visits
(ranging between 9 to 48 sessions) in studies that offered post-op PFMT28,39. Therefore,
initiating PT interventions pre-op translates to a potential cost saving for patients and the
healthcare system by reducing the total number of visits required for successful motor
learning to occur.
Future research
Both the retrospective and prospective studies were conducted based on patients coming
from one surgical clinic. The data was collected by one physical therapist and therefore
the results are biased and not generalizable to the larger population and geography. A
study which would include several clinical sites and in various States, provided that there
is standardization between surgeons and therapists, would allow for better
generalizability.
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Furthermore, this was a pilot study and the sample only included 20 men. A similar
study with a larger sample size needs to be conducted to verify the results found in this
pilot study. A larger sample size would thereby allow for greater statistical power.
In this study, the pre-op session was performed less than 3 weeks prior to surgery and did
not identify PF strength pre-op as a predictor of UI post-op. However, our results did
show a relationship between PF strength and UI which was getting stronger over time.
Men who had good PF strength were less likely to experience UI. Therefore, a study
where the pre-op session is performed a month prior to surgery may allow sufficient time
for improved PF bulk to occur and possibly then render PF strength to have an effect on
UI post-op.
Of all potential associated factors analyzed only race was found to be significant. Nonwhites were experiencing more UI than whites, however only at the 3 months post-op
time point in the retrospective study. It would be interesting to study a larger sample
with non-whites to see whether this was an aberrant finding or not.
Finally, the portion of our study that investigated the impact of UI on QoL noted
significantly less impact in the PFMT group at 6 weeks. QoL scores were even better
than the control group at 3 months post-op. A study that would look at QoL at 6 weeks
post-op comparing men who received a pre-op PFMT to men who received immediate
post-op PFMT would further corroborate the importance and advantages of a pre-op
session if similar findings were noted.
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LIMITATIONS AND DELIMITATIONS
The primary limitations of this research pertains to its generalizability. The small sample
size of the pilot study as discussed previously is a limitation. Also, the research was
limited to one clinic and surgical site, thereby limiting the selection of men who
underwent RARP to local and primarily white men. In 2018, the census bureau140 notes a
population consisting of 60.7% Whites, 13.4% Blacks, 5.8% Asians, and 18.1%
Hispanics. The retrospective study consisted of 89.3% Whites, and only 8.6% Blacks
and 2% Hispanics, and the prospective study has 90% Whites and 5% each of Blacks and
Asians, and thus not representative of the general population. Furthermore, delimitations
in the prospective study are associated with the inclusion criteria which influence the
generalizability of the findings further. The inclusion criteria were chosen to assure a
more homogenous group for comparison purposes. However, in this age group it is not
uncommon to have co-morbidities and thus this sample is not representative of the
general population and findings cannot be generalized.
Another limitation in the retrospective study stems from the nature of such analysis. This
type of research does not allow for experimental control over the original data collection
process. Demographics and clinical data was extrapolated from the medical records of
consecutive men who received RARP between the years of 2008 and 2016. Because of
missing data, in order to reach the required sample size, the year of surgery was extended
to prior to this therapist s collaboration with the surgeons and thus original data was also
gathered by two other therapists. Standardization of protocol between the therapists
could not be established. However, these other therapists are known to this investigator
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and have completed similar training in the assessment of male PF strength. Therefore,
data was deemed to be included and supports the validity of the findings.
In the prospective study all the measurements were performed by the same examiner and
therefore the examiner was not blinded to group assignment. Also all RARP were
performed by the same surgeon. This represents examiner and surgeon bias, however it
improved the reliability of the measurements and procedure.
The benefits and results of a PFMT to improve PF strength and improve the symptoms of
urinary incontinence are contingent to patient compliance and motivation. The measure
of the severity of UI relied on the number of pads used per day, which represents a semiquantitative and subjective measure. It also relied on functional questionnaires which are
self-reporting measures. Men who participated in the prospective study were aware that
the measure of severity of UI was the primary purpose of the research and possibly
wanted to show good results and thus may affect our findings.
Due to the variability of the definition of continence and measure used in other studies, as
well as the lack of a standard protocol for the PFMT session between studies, the results
of our study cannot accurately be compared to previous studies.
Finally, the lack of normality and homogeneity of group variances and linearity among
the predictors, as well as the small sample size of the prospective study which required
the use of non-parametric statistics decrease the statistical power of the analyses.
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SUMMARY
The primary aim of this research was to explore the relationship between receiving a onetime pre-operative PFMT and the occurrence of post-operative urinary incontinence and
the impact on quality of life in men following a da Vinci robotic-assisted radical
prostatectomy (RARP). Four questions were developed in order to examine this
relationship. The first two questions were explored through a retrospective study and
included whether the men who received the pre-op PFMT had less incontinence than
those who did not, as well as the factors that may be associated with less incidence of
urinary incontinence post-op. The next two questions were explored through a cohort
prospective study and included whether the men who presented with the predictive
factors identified in the retrospective study had less incontinence than those who did not,
and whether men who have received the one-time pre-op PFMT session present with
improved PF strength, less incontinence, and better quality of life scores immediately
following the robotic assisted daVinci prostatectomy compared to those who did not.
The analysis conducted to answer the first question shows a strong association between
PFMT pre-op and decreased incidence of UI post-op at 6 weeks, 3 months and 12 months
post-op with the strongest effect being at 6 weeks. Furthermore, the one single session
pre-op provided by a physical therapist was sufficient based on the results.
The analysis conducted to answer the second question failed to identify any factors,
including PF strength and demographic variables that were associated with less incidence
of urinary incontinence post-op except for race at 3 months, in that non-whites were more
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likely to have UI, however this did not affect the relationship between PFMT and
incontinence.
The analysis conducted to answer the third question also showed that none of the
demographics pre-op were related to incontinence post-op, but it did show a trend
towards a likelihood of not experiencing UI post-op with good PF strength/endurance,
less likelihood of UI with fair PF strength/endurance, and almost certain UI with
poor PF strength/endurance at both 6 weeks and 3 months post-op with the relationship
between PF strength/endurance and incontinence getting stronger over time.
Finally, the analysis conducted to answer the fourth question show that PF strength and
endurance improve significantly over time for all men, however more rapidly in those
who have received the pre-op PFMT. Incontinence is significantly more likely in men
who did not receive PFMT at 6 weeks and 3 months with the strongest effect at 6 weeks.
The functional impact of incontinence also gets smaller over time in both groups, but
with a significant lesser impact on QoL in the PFMT group. The impact at 3 months is
higher in the control group than at 6 weeks in the PFMT group.
Conclusion
Therefore, based on the findings of the study and evidence presented this study supports
the benefits of a pre-op PFMT program. Prophylactic PFMT could be recommended for
all patients undergoing RARP and could be part of the guidelines for management of UI
as a routine pre-op preparation prior to RARP in urology practice. Giving men who will
be undergoing RARP confidence pre-op that urine can be controlled post-op would help
overcome the physical, psychosocial, and emotional problems derived from loss of
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bladder control. It would further translate to cost savings for the patients and the
healthcare system by reducing the total number of PT visits required to achieve
continence post-op, by reducing the cost of purchase of incontinence products, and/or by
reducing the cost induced by additional surgical intervention.
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Appendix A: Letter of Support
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Appendix B: Data Collection Form Retrospective

Data Collection Form Retrospective Study
- Subject # _______
- Date of surgery _________
- Group Assignment: PFMT
Control
Excluded
Pre-op
Age (years)
Race/Ethnicity
Level of Education

White

Black

HighElementar
schoo College
y
l

Weight (kg)
Height (m)
BMI (kg/m²
PSA (ng/ml)
Symptoms

Yes

No

secs

reps

Gleason Score (2-10)
Clinical T-stage (IIV)
PFM Strength (1-5/5)
PFM Endurance (110)

Hispani
c
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Other
Postgraduat
e

Intra-op
Bladder neck preserved

Yes

No

NVB preserved

Yes

No

Post-op 6 weeks
UI

Yes

No

Yes

No

Yes

No

Complications

Yes

No

PT

Yes

No

Intervention

Yes

No

Number of pads/day
Post-op 3 months
UI
Number of pads/day
Post-op 12 months
UI
Number of pads/day
Other post-op
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Appendix C: Informed Consent

INFORMED CONSENT
Consent Form for Participation in the Research Study entitled: Does one Session of Preoperative Pelvic Floor Muscle Training aid in improving Urinary Incontinence
immediately following Robotic Assisted Radical Prostatectomy: A Retrospective and
Pilot Study
Primary Investigator:
Francine Noel-Ford, PT, DPT, OCS
7768 Williamson Rd
Roanoke, VA 24019
(540)985-0500
francine@backtobasicspt.com
Co- Investigators:
Shari Rone-Adams, PT, MHSA, DBA
M. Samuel Cheng, PT, MS,ScD
3200 South University Drive
3200 South University Drive
Ft. Lauderdale, FL 33328
Ft. Lauderdale, FL 33328
(954) 262-1740
(954)262-1273
srone@nova.edu
mingshun@nova.edu
Data Collection Sites:
Back to Basics Family Physical Therapy
7768 Williamson Rd
Roanoke, VA 24019
(540)985-0500

Jefferson Surgical Clinic
1234 Franklin Rd, SW
Roanoke, VA 24016
(540)283-6000

What is the purpose of this study?
You are invited to be in a research study. The purpose of this research study is to
determine whether one session of pre-operative pelvic floor muscle training aids in
improving the symptoms of urinary incontinence immediately following a robotic
assisted radical prostatectomy. We will be comparing the results with men who did not
receive the pre-operative session. Research studies are designed to gain scientific
knowledge that may help other people in the future. Your participation is voluntary.
Please take your time to make your decision, and ask the investigator to explain any
words or information that you do not understand. You may also discuss the study with
your physician, friends and family.
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Why are you asking me?
You are being asked to participate in this study because you are a male who will be
undergoing the robotic assisted radical prostatectomy. You will be randomly assigned to
either receive the pre-operative training or not receive the pre-operative training session.
Men who will not receive the one session training are being asked to participate to be part
of a control group so we can compare differences in urinary incontinence following the
surgical intervention between the two groups.
What procedures are involved if I agree to be in the study?
First, a licensed physical therapist will perform a brief interview to determine if you fit
the criterion for inclusion in the study. If you meet the study criteria you will then be
asked to fill out a questionnaire. You will be asked to answer questions about your age,
occupation, personal health history and some urinary and bladder function specific
questions. This part of the study will take approximately 15 minutes. Next, the physical
therapist will conduct a physical examination which consists of assessing your pelvic
floor muscle strength and endurance. The tests that will be used in this examination are
tests which are routinely used by physical therapists in evaluating the pelvic floor muscle.
You will be instructed specifically on what you need to do throughout the testing session.
You will be placed in the side lying position for ease of access and visualization of the
perineum. The strength will be assessed through rectal digital palpation. You will be
asked to squee e your pelvic floor muscles around the therapist s finger as hard as you
can by pulling the finger up and in. Endurance will be tested through the use of a selfadherent electrode placed on the perineal region between the anus and the scrotum. The
electrode is connected to a biofeedback unit which records the activity of the muscle. For
the first measure of endurance, you will be asked to contract the pelvic floor muscles as
hard as possible and to sustain the contraction for up to 10 seconds. After a 60 seconds
rest period, the second measure of endurance will be taken. You will be asked to repeat
as many strong contractions as possible by contracting the pelvic floor muscles for 2
seconds and resting for 4 seconds up to 10 contractions. These measures will take
approximately 15 min and will allow the therapist to grade your pelvic floor muscle
strength and endurance.
What are the potential risks and discomfort?
The risk of harm or discomfort that may happen as a result of taking part in this research
study is not expected to be more than in daily life or from routine physical or
psychological examinations or tests. In healthy adults the risks from performing the
anticipated tests are remote. The only foreseeable discomfort would be limited to a
muscle soreness following the rectal digital examination. This risk will be reduced by
appropriate handling and detailed instructions to ensure that the test is performed
correctly.
If you have any concerns about the risks or benefits of participating in this study, you can
contact Francine Noel-Ford, PT, DPT, OCS, Shari Rone-Adams, PT, MHSA, DBA, M.
Samuel Cheng, PT, MS, ScD, or the IRB office at the numbers indicated above.
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Are there any benefits to me for taking part in this research study?
You are not expected to receive any direct benefit from taking part in this research study.
However, we hope that this research will eventually lead to strategies for preventing the
severity of urinary incontinence following prostatectomy and that the information learned
from this study will benefit other people in the future.
What are the costs for participating in this research?
There are no costs to you if you choose to participate in this research, except for your
time.
How will you keep my information confidential and private?
Taking part in this research study may involve providing information that you consider
confidential or private. Efforts, such as coding research records, keeping research records
secure and allowing only the authorized researcher to have access to research records,
will be made to keep your information safe.
To ensure the privacy and confidentiality of your personal health information, as well as
information that directly identifies you, the investigator will employ a sequential numeric
coding system that eliminates the ability to identify you directly from the research
records. Access to the computer dataset will be password protected and limited to the
primary investigator. All data and reports created as a result of your participation in the
research study will be entered into the secured computer systems of Back to Basics
Family Physical Therapy. These will be kept secure, with access to this information
limited to individuals with proper authority. All information obtained from this study will
be stored in a locked cabinet in the principle investigators office. All information
obtained from this study is strictly confidential unless disclosure is required by law.
Use of Protected Health Information (PHI):
As part of this study, you are asked to authorize Francine Noel-Ford, PT, DPT, OCS,
Shari Rone-Adams, PT, MHSA, DBA, M. Samuel Cheng, PT, MS, ScD access to your
personal health information that is related to this study. Examples of your personal health
information include your health history, how you respond to study test procedures, and
physical examinations. Your personal health information and information that identifies
you will not be given to others during or after the study. The purpose of this authorization
is to allow the researcher to obtain the following specific information to be used as part of
this research study, to determine the results of the study, to make sure the study is being
done correctly and to provide required reports. Any information given would be deidentified.
You may change your mind and revoke (take back) this authorization at any time, except
to the extent that the researchers have already acted based on this authorization.
To revoke this authorization you must write to:
Francine Noel-Ford, PT, DPT, OCS
Shari Rone-Adams, PT, MHSA,
DBA
7768 Williamson Rd
or
3200 South University Drive
Roanoke, VA 24019
Ft. Lauderdale, FL 33328
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Refusing to participate or leaving the study will not result in any penalty. If you decide to
stop participating in the study there are no potential health or safety consequences. The
investigators also have the right to stop your participation in the study at any time. This
could be because it is in your best medical interest, your condition worsened, new
information becomes available, you had an unexpected reaction, or you failed to follow
instructions. If significant new information relating to the study becomes available which
may relate to your willingness to continue to participate, this information will be
provided to you by the investigators.
You have the right to refuse to sign this authorization and informed consent. This will not
result in any penalty but you will be unable to participate in the procedures associated
with this research study.
You have the right to inspect or copy your Protected Health Information to be used or
disclosed as permitted under federal and state law (whichever gives you greater access
rights). Participating in this study does not affect your rights to inspect or copy your
Protected Health Information.
Can I withdraw or be removed from the study?
You have the right to refuse to participate or to withdraw at any time, without penalty. If
you choose to withdraw, your data will not be destroyed and will be kept for the length of
this study plus three years. Your health information that has already been gathered may
still be used and disclosed to others. This would be done if it were necessary for the
research to be reliable.
Voluntary Consent by Participant:
By signing below, you indicate that
this study has been explained to you
you have read this document or it has been read to you
your questions about this research study have been answered
you have been told that you may ask the researchers any study related
questions in the future or contact them in the event of a research-related
injury
you have been told that you may ask Institutional Review Board (IRB)
personnel questions about your study rights
you are entitled to a copy of this form after you have read and signed it
you voluntarily agree to participate in the study entitled Does one Session of
Pre-operative Pelvic Floor Muscle Training aid in improving Urinary
Incontinence immediately following Robotic Assisted Radical Prostatectomy:
A Retrospective and Pilot Study.
Participant's Signature: ___________________________ Date: ________________
Witness's Signature: _____________________________ Date: __________________
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Appendix D: Data Collection Form Prospective

Data Collection Form Prospective Study
- Subject # _______
- Date to test _________
- Date of surgery _________
Group Assignment: PFMT
Control
Excluded
Pre-op
Age (years)
Race/Ethnicity
Level of Education

White

Black

HighElementar
schoo College
y
l

Weight (kg)
Height (m)
BMI (kg/m²
PSA (ng/ml)
Symptoms

Yes

No

secs

reps

Gleason Score (2-10)
Clinical T-stage (IIV)
PFM Strength (1-5/5)
PFM Endurance (110)

Hispani
c
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Other
Postgraduat
e

Intra-op
Bladder neck preserved

Yes

No

NVB preserved

Yes

No

Yes

No

Post-op 6 weeks
UI
Number of pads/day
IIQ-7
UCLA-PI
PFM Strength (1-5/5)
PFM Endurance (1-10)

secs

reps

Post-op 3 months
UI

Yes

No

Number of pads/day
IIQ-7
UCLA-PI
PFM Strength (1-5/5)
PFM Endurance (1-10)

secs

reps

95

Appendix E: Hand-outs anatomy/physiology
(©2000, Progressive Therapeutics, PC)
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Appendix F: Hand-outs HEP/Bladder Diary
(©2000, Progressive Therapeutics, PC)
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Keeping a Record of Bladder Function
The main purpose of a bladder diary is to document how your bladder functions. A diary
can give your health care provider an excellent picture of your bladder functions, habits,
and patterns. At first, the diary is used as an evaluation tool. Later, it will be used to
measure your progress on bladder retraining.
Please complete a bladder diary and bring it with you to your appointment.
Your diary will be more accurate if you fill it out as you go through the day. It can be
very difficult to remember at the end of the day exactly what happened in the morning.
Instructions
Column 1 Time of Day
The log begins with midnight and covers a 24 hour period. Afternoon times are bold.
Select the hour block that corresponds with the time of day you are recording.
Column 2 Type and Amount of Fluid and Food Intake
Record the type and amount of fluid you drank
Record the type and amount of food you ate
Record when you woke up for the day and the hour you went to
sleep
Column 3 Amount Voided
Record the time of day and amount of urine emptied by writing the number of ounces
voided, marking S for Small amount, M for Medium amount, L for Large amount, or the
number of seconds taken to void.
Column 4 Amount of leakage
Record the amount of urine loss at the time it occurred
S Small = drop or two of urine
M- Medium = wet underwear
L- Large = wet outwear or floor
Column 5 Was Urge Present?
Describe the urge sensation you had as:
1- MILD = first sensation of need to go
2- MODERATE = stronger sensation or need
3- STRONG = need to get to toilet, move aside!
Column 6 Activity with Leakage/Notes
Describe the activity associated with the leakage, i.e., coughed, heard running water,
sneezed, bent over, lifted something, or had a strong urge.
Comments Special problems and new or changed medications go here. If a pad change
was needed, record the number used during the day at the bottom of the page
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Appendix G: HEP log

HOME EXERCISE PROGRAM LOG
Please complete log daily
Mark on X in each box as you have completed a set of pelvic floor exercises
Also mark whether you have completed a pelvic brace and the activity/ies
performed

Week #

Fast
Twitches

Slow
Twitches

Day 1
Day 2
Day 3
Day 4
Day 5
Day 6
Day 7
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Pelvic Brace

Appendix H: IIQ-7

Incontinence Impact Questionnaire, Short
Form (IIQ-7)
Incontinence Impact Questionnaire, Short Form (IIQ-7)
Has urine leakage affected your:

1. Ability to do household chores
(cooking, housecleaning, laundry)?
2. Physical recreation such as walking,
swimming,
or other exercise?
3. Entertainment activities (movies,
concerts, etc)?
4. Ability to travel by car or bus more
than 30
minutes from home?
5. Participation in social activities outside
your
home?
6. Emotional health (nervousness,
depression,
etc)?
7. Feeling frustrated?
TOTAL

Not at
all

Slightly Moderately Greatly

Patient
Score

0

1

2

3

__

0

1

2

3

__

0

1

2

3

__

0

1

2

3

__

0

1

2

3

__

0

1

2

3

__

0

1

2

3

__
__

Scoring.The average score of items responded to is calculated. The average, which
ranges from 0 to 3, is multiplied by 33 1/3 to put scores on a scale of 0 to 100.
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Appendix I: UCLA-PCI
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If any part of the material to be used (for example, figures) has appeared in our
publication with credit or acknowledgement to another source, permission must
also be sought from that source. If such permission is not obtained then that
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